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11. PUBLIC HEALTH STATEMENT
This Statement was prepared to give you information about silver and to
emphasize the human health effects that may result from exposure to it. The
Environmental Protection Agency (EPA) has identified 1177 sites on its
National Priorities List (NPL). Silver has been found at 27 of these sites.
However, we do not know how many of the 1177 NPL sites have been evaluated for
silver. As EPA evaluates more sites, the number of sites at which silver is
found may change. The information is important for you because silver may
cause harmful health effects and because these sites are potential or actual
sources of human exposure to silver.
When a chemical is released from a large area, such as an industrial
plant, or from a container, such as a drum or bottle, it enters the
environment as a chemical emission. This emission, which is also called a
release, does not always lead to exposure. You can be exposed to a chemical
only when you come into contact with the chemical. You may be exposed to it
in the environment by breathing, eating, or drinking substances containing the
chemical or from skin contact with it.
If you are exposed to a hazardous substance such as silver, several
factors will determine whether harmful health effects will occur and what the
type and severity of those health effects will be. These factors include the
dose (how much), the duration (how long), the route or pathway by which you
are exposed (breathing, eating, drinking, or skin contact), the other
chemicals to which you are exposed, and your. individual characteristics such
as age, sex, nutritional status, family traits, life style, and state of
health.
1.1 WHAT IS SILVER?
Silver is one of the basic elements that make up our planet. Silver is
rare, but occurs naturally in the environment as a soft, "silver" colored
metal. Because silver is an element, there are no man-made sources of silver.
People make jewelry, silverware, electronic equipment, and dental fillings
with silver in its metallic form. It also occurs in powdery white (silver
nitrate and silver chloride) or dark-gray to black compounds (silver sulfide
and silver oxide). Silver could be found at hazardous waste sites in the form
of these compounds mixed with soil and/or water. Therefore, these silver
compounds will be the main topic of this profile. Throughout the profile the
various silver compounds will at times be referred to simply as silver.
Photographers use silver compounds to make photographs. Photographic
materials are the major source of the silver that is released into the
environment. Another source is mines that produce silver and other metals.
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The natural wearing down of silver-bearing rocks and soil by the wind and rain
also releases large amounts of silver into the environment.
Silver that is released into the environment may be carried long
distances in air and water. Rain washes silver compounds out of many soils so
that it eventually moves into the groundwater. Silver is stable and remains
in the environment in one form or another until it is taken out again by
people. Because silver is an element, it does not break down, but it can
change its form by combining with other substances. Over time it may change
from the form first released, to metallic silver, and then back to the same or
other compounds. The form it is found in depends on environmental conditions.
More information on the chemical and physical properties of silver compounds
can be found in Chapter 3, on its production, use, and disposal in Chapter 4,
and on silver in the environment in Chapters 4 and 5.
1.2 HOW MIGHT I BE EXPOSED TO SILVER?
Most people are exposed daily to very low levels of silver mainly in food
and drinking water, and less in air. The silver in these sources is at least
partially due to naturally occurring silver in water and soil. Skin contact
and breathing in air containing silver compounds also occurs in the workplace.
Other sources of exposure include the use of silver in medicines, and in
activities such as jewelry-making, soldering, and photography. Exposure from
everyday use, such as wearing jewelry or eating with silver-coated flatware,
is not expected to result in silver being taken into the body.
Silver levels of less than 0.000001 mg silver per cubic meter of air
(mg/m3), 0.2-2.0 parts silver per billion parts water (ppb) in surface waters,
such as lakes and rivers, and 0.20-0.30 parts silver per million parts soil
(ppm) in soils are found from naturally occurring sources. Silver compounds
are also found in groundwater and at hazardous waste sites throughout the
United States. Drinking water supplies in the United States have been found
to contain silver levels of up to 80 ppb. Surveys show that one-tenth to one-
third of samples taken from drinking water supplies (both groundwater and
surface water) contain silver at levels greater than 30 ppb. For more
information on exposure to silver see Chapter 5.
1.3 HOW CAN SILVER ENTER AND LEAVE MY BODY?
Silver may enter your body through the mouth, throat, or digestive tract
after eating food or drinking water that contains silver, or through your
lungs after breathing air containing silver. It can also enter your body
through your skin when you put your hands into solutions containing silver
compounds, such as those used in photography, or when you come in contact with
silver-containing powders. Silver is also known to enter the body when
medicines containing it are taken or applied to the skin or gums. Generally,
much less silver will enter the body through the skin than through the lungs or
stomach.
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Because many silver compounds dissolve in water and do not evaporate, the
most common way that silver may enter the body of a person near a hazardous
waste site is by drinking water that contains silver or eating food grown near
the site in soil that contains silver. Silver can also enter the body when
soil that has silver in it is eaten. Most of the silver that is eaten or
breathed in leaves the body in the feces within about a week. Very little
passes through the urine. It is not known how much of the silver that enters
the body through the skin leaves the body. Some of the silver that is eaten,
inhaled, or passes through the skin may build up in many places in the body.
More information on how silver enters and leaves the body can be found in
Chapter 2.
1.4 HOW CAN SILVER AFFECT MY HEALTH?
Since at least the early part of this century, doctors have known that
silver compounds can cause some areas of the skin and other body tissues to
turn gray or blue-gray. Doctors call this condition "argyria." Argyria
occurs in people who eat or breathe in silver compounds over a long period
(several months to many years). A single exposure to a silver compound may
also cause silver to be deposited in the skin and in other parts of the body;
however, this is not known to be harmful. It is likely that many exposures to
silver are necessary to develop argyria. Once you have argyria it is
permanent. However, the condition is thought to be only a "cosmetic" problem.
Most doctors and scientists believe that the discoloration of the skin seen in
argyria is the most serious health effect of silver.
Exposure to dust containing relatively high levels of silver compounds
such as silver nitrate or silver oxide may cause breathing problems, lung and
throat irritation and stomach pain. These effects have been seen in workers
in chemical manufacturing facilities that make silver nitrate and silver
oxide. One man developed severe breathing problems shortly after working with
molten silver. Skin contact with silver compounds has been found to cause
mild allergic reactions, such as rash, swelling, and inflammation, in some
people.
Studies of the health effects of silver in animals commonly use silver
nitrate. Doctors and scientists assume that effects seen using silver nitrate
in animals will be very similar to effects in humans caused by any silver
compound. While this is likely to be true, it is still possible that some
silver compounds will be more harmful, or toxic, than silver nitrate.
One animal study suggests that long-term exposure (125 days) to
moderately high levels of silver nitrate in drinking water may have a slight
effect on the brain because exposed animals were less active than animals
drinking water without silver. Another study found that some of the animals
that drank water containing moderately high levels of silver for most of their
lives (9 months or longer) had hearts that were larger than normal. It is not
yet known whether these effects would occur in humans. There have been
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suggestions in some occupational studies in humans that silver can cause
kidney problems; however, more people exposed to silver need to be studied to
find out if silver causes these effects.
No studies of cancer or birth defects in animals from eating, drinking,
or breathing in silver compounds were found. Therefore, it is not known if
these effects would occur in humans. One study of animals drinking silver
compounds mixed with water for most of their life found no effect on
fertility. Another study found that reproductive tissues were damaged in
animals after they received injections of silver nitrate. However, the
tissues recovered even while the animals received more injections of silver
nitrate. Tests in animals show that silver compounds are likely to be life-
threatening for humans only when large amounts (that is, grams) are swallower
and that skin contact with silver compounds is very unlikely to be
lifethreatening.
Silver does have helpful uses. For example, silver nitrate was used for
many years as drops in newborns' eyes to prevent blindness caused by
gonorrhea, and is also used in salves for burn victims. Some water treatment
methods (including water filters) also use a form of silver to kill bacteria.
More information on the health effects from exposure to silver is presented in
Chapter 2. More information on the helpful uses of silver is presented in
Chapter 4.
1.5 WHAT LEVELS OF EXPOSURE HAVE RESULTED IN HARMFUL HEALTH EFFECTS?
Reports of cases of argyria suggest that gram amounts of a silver
compound taken in medication in small doses over several months may cause
argyria in some humans. People who work in factories that manufacture silver
compounds can also breathe in the compounds. In the past, some of these
workers have become argyric. However, the level of silver in the air and the
length of exposure that caused argyria in these workers is not known. It is
also not known what level of silver causes breathing problems, lung and throat
irritation, or stomach pain in people.
Studies in rats show that drinking water containing very large amounts of
silver (2589 parts of silver per million parts of water, or about 2.6 grams
per liter) is likely to be life-threatening.
There is very little information about health effects following skin
contact with silver compounds. Argyria that covers the entire body is not
seen following skin contact with silver compounds, although the skin may
change color where it touches the silver. However, many people who have used
skin creams containing silver compounds such as silver nitrate and silver
sulphadiazine have not reported health problems from the silver in the
medicine. In one animal study, a strong solution of silver nitrate (about 41
grams of silver nitrate per liter of water which is equal to 41 parts of
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silver nitrate per thousand parts of water) applied to the skin of guinea pigs
for 28 days did not cause the animals to die; however, it did cause the guinea
pigs to stop gaining weight normally. It is not known if this would happen to
people if they were exposed the same way.
Tables l-1 through l-4 present the information that is available
concerning specific levels of exposure and health effects. The amount of
silver that has caused death in rats, and that has caused mice to be less
active are shown in Table 1-4.
1.6 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN EXPOSED TO SILVER?
There are reliable and accurate ways of measuring silver in the body.
Silver can be measured in the blood, urine, feces, and body tissues of exposed
individuals. Because urine and blood samples are easy to get, these fluids
are most often used to find out if a person has been exposed to silver in the
last week or so. Silver builds up in the body, and the best way to learn if
past exposure has occurred is to look for silver in samples of skin. Tests
for silver are not commonly done at a doctor's office because they require
special equipment. Although doctors can find out if a person has been exposed
to silver by having blood or skin samples examined, they can not tell whether
any health effects will occur. Information about tests for measuring silver
in the body is in Chapters 2' and 6.
1.7 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO PROTECT HUMAN
HEALTH?
The federal government has developed regulations and guidelines to
protect people from the possible health effects from long-term exposure to
silver in drinking water. The Environmental Protection Agency (EPA) suggests
that the level of silver in drinking water not be more than 0.05 milligrams
per liter of water (mg/L) (which is equal to 50 parts of silver per billion
parts of water or ppb). However, in May, 1989, the EPA announced that this
restriction on silver levels in drinking water might be removed. For shortterm
exposures (l-10 days), EPA suggests that drinking water levels of silver
not be more than 1.142 mg/L (which is equal to 1.142 parts of silver per
million parts of water or ppm).
Any release to the environment of more than 1 pound silver nitrate or
1000 pounds of silver alone should be reported to the National Response
Center. To limit the amount silver workers are exposed to during an 8-hour
shift for a 40-hour work week, the Occupational Safety and Health
Administration (OSHA) has set a legal limit (Permissible Exposure Limit or
PEL) of 0.01 milligrams of silver per cubic meter of air (mg/m3) in workroom
air.
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For more information on criteria and standards for silver exposure, see
Chapter 7.
1.8 WHERE CAN I GET MORE INFORMATION?
If you have any more questions or concerns not covered here, please
contact your State Health or Environmental Department or:
Agency for Toxic Substances and Disease Registry
Division of Toxicology
1600 Clifton Road, E-29
Atlanta, Georgia 30333
This agency can also give you information on the location of the nearest
occupational and environmental health clinics. Such clinics specialize in
recognizing, evaluating, and treating illnesses that result from exposure to
hazardous substances.
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2. HEALTH EFFECTS
2.1 INTRODUCTION
This chapter contains descriptions and evaluations of studies and
interpretation of data on the health effects associated with exposure to
silver. Its purpose is to present levels of significant exposure for silver
based on toxicological studies, epidemiological investigations, and
environmental exposure data. This information is presented to provide public
health officials, physicians, toxicologists, and other interested individuals
and groups with (1) an overall perspective of the toxicology of silver and (2)
a depiction of significant exposure levels associated with various adverse
health effects.
Silver occurs naturally in several oxidation states. The most common are
elemental silver (0 oxidation state) and the monovalent silver ion (+l
oxidation state). Most of the toxicological studies of silver have
investigated these chemical forms of the element. Other possible oxidation
states of silver are +2 and +3, however, no toxicological studies were located
that researched the health effects of silver compounds with these oxidation
states. Most occupational exposures to silver occur through inhalation of
silver-containing dusts or dermal exposure to photographic compounds.
Published studies on human inhalation of silver are based predominantly on
exposure to elemental silver, silver nitrate, and silver oxide. Human oral
data come from information on medicines containing silver, such as silver
acetate-containing antismoking lozenges, breath mints coated with silver, and
silver nitrate solutions for treating gum disease. Animal studies usually are
based on exposure to silver nitrate and silver chloride in drinking water.
Humans may be dermally exposed to silver through the use of silver-containing
processing solutions for radiographic and photographic materials, dental
amalgams, and medicines (e.g., silver sulphadiazine cream and solutions for
treating burns).
2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE
To help public health professionals address the needs of persons living
or working near hazardous waste sites, the data in this section are organized
first by route of exposure -- inhalation, oral, and dermal -- and then by
health effect -- death, systemic, immunological, neurological, developmental,
reproductive, genotoxic, and carcinogenic effects. These data are discussed
in terms of three exposure periods -- acute, intermediate, and chronic.
Levels of significant exposure for each exposure route and duration (for
which data exist) are presented in tables and illustrated in figures. The
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points in the figures showing no-observed-adverse-effect levels (NOAELS) or
lowest-observed-adverse-effect levels (LOAELS) reflect the actual doses
(levels of exposure) used in the studies. LOAELs have been classified into
"less serious" or "serious" effects. These distinctions are intended to help
the users of the document identify the levels of exposure at which adverse
health effects start to appear, determine whether or not the intensity of the
effects varies with dose and/or duration, and place into perspective the
possible significance of these effects to human health.
The significance of the exposure levels shown on the tables and graphs
may differ depending on the user's perspective. For example, physicians
concerned with the interpretation of clinical findings in exposed persons or
with the identification of persons with the potential to develop such disease
may be interested in levels of exposure associated with "serious" effects.
Public health officials and project managers concerned with response actions
at Superfund sites may want information on levels of exposure associated with
more subtle effects in humans or animals (LOAEL) or exposure levels below
which no adverse effects (NOAEL) have been observed. Estimates of levels
posing minimal risk to humans (Minimal Risk Levels, MRLs) are of interest to
health professionals and citizens alike.
Estimates of exposure posing minimal risk to humans (MRLs) have been
made, where data were believed reliable, for the most sensitive noncancer end
point for each exposure duration. MRLs include adjustments to reflect human
variability and, where appropriate, the uncertainty of extrapolating from
laboratory animal data to humans. Although methods have been established to
derive these levels (Barnes et al. 1987; EPA 1989a), uncertainties are
associated with the techniques. Furthermore, ATSDR acknowledges additional
uncertainties inherent in the application of these procedures to derive less
than lifetime MRLs. As an example, acute inhalation MRLs may not be
protective for health effects that are delayed in development or are acquired
following repeated acute insults, such as hypersensitivity reactions, asthma,
or chronic bronchitis. As these kinds of health effects data become available
and methods to assess levels of significant human exposure improve, these MRLs
will be revised.
2.2.1 Inhalation Exposure
2.2.1.1 Death
No studies were located regarding death in humans or animals after
inhalation exposure to silver or silver compounds.
2.2.1.2 Systemic Effects
No studies were located regarding cardiovascular or musculoskeletal
effects in humans or animals after inhalation exposure to silver or silver
compounds.
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Respiratory Effects.  Respiratory effects have been observed infrequently
in humans following inhalation of silver compounds. In one case report of a
worker who had become ill 14 hours after he had been working with molten
silver ingots, symptoms were limited primarily to the respiratory system
(Forycki et al. 1983). Unfortunately, the concentration and chemical
composition of the silver in the work room air were not known, and the history
of exposure to silver prior to this incident was not reported. The initial
symptoms seen in this patient included audible crackles during breathing,
rapid pulse, low oxygen content of capillary blood, and scattered thickening
of the lungs observed in chest radiograms. The patient's symptoms progressed
to acute respiratory failure, from which the patient eventually recovered
fully.
Occupational exposure to silver dusts can also lead to respiratory
irritation (Rosenman et al. 1979, 1987). One occupational study describes a
group of 30 employees of a manufacturing facility involved in the production
of silver nitrate and silver oxide (Rosenman et al. 1979). The average air
level of these silver compounds over the duration of the workers' exposure was
not estimated. However, personal air monitoring conducted 4 months previous
to the study determined an 8 hour time-weighted average (TWA) concentration
range of 0.039 to 0.378 mg silver/m3. Duration of employment ranged from less
than one, to greater than ten years. Twenty-five of the 30 workers complained
of upper respiratory irritation (sneezing, stuffiness, and running nose or
sore throat) at some time during their employment, with 20 out of 30
complaining of cough, wheezing, or chest tightness. Chest radiograms and
results of clinical examination of respiratory function were predominantly
normal, with no demonstrated relationships between abnormalities and duration
of employment. Similar complaints were recorded for workers involved in the
manufacture of silver metal powders, although the workers were concurrently
exposed to acids, hydroquinone, formaldehyde, caustics, solvents, and cadmium
(Rosenman et al. 1987).
Acute (2-8 hours) inhalation of an aerosol containing colloidal silver by
rabbits (whole body exposure, concentrations not given) has been reported to
lead to ultrastructural damage and disruption of cells of the tracheal
epithelium (Konradova 1968).
Gastrointestinal Effects.  Abdominal pain has also been reported by
workers exposed to silver nitrate and oxide in the workplace (Rosenman et al.
1979). The pain was described as "burning in quality and relieved by
antacids" and was reported in 10 out of 30 workers examined. Exposure levels
were estimated to be between 0.039 and 0.378 mg silver/m3. No information on
chemical form or particle size was provided. Duration of employment ranged
from less than one, to greater than ten years. This symptom correlated
significantly with blood silver levels, indicating that those workers exposed
to higher levels of airborne silver nitrate and/or oxide are more likely to
suffer gastrointestinal pain.
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No studies were located regarding gastrointestinal effects in animals
following inhalation exposure to silver or silver compounds.
Hematological Effects.  Blood counts were reported to be normal in all
individuals observed in the occupational study of silver-exposed workers
conducted by Rosenman et al (1979) with the exception of one individual with
an elevated hemoglobin level. In a study by Pifer et al. (1989), silver
reclamation workers chronically exposed to insoluble silver compounds (e.g.,
the silver halides) exhibited a marginal decrease in red blood cell count, as
well as an increase in mean corpuscular volume. However, the toxicological
significance of these findings is unclear.
No studies were located regarding hematological effects in animals
following inhalation exposure to silver or silver compounds. Despite the lack
of supportive animal data, occupational exposure findings suggest that
hematological effects are not a sensitive indicator of silver toxicity.
Hepatic Effects.  A study that measured levels of several liver enzymes
(alanine amino transferase, aspartate amino transferase, gamma glutamyl
transferase, and alkaline phosphatase) found no significant differences
between workers exposed to silver and insoluble silver compounds and those
with no history of silver exposure (Pifer et al. 1989).
No studies were located regarding hepatic effects in animals following
inhalation exposure to silver or silver compounds.
Renal Effects.  Occupational exposure to silver metal dust has been
associated with increased excretion of a particular renal enzyme (N-acetyl-β-D
glucosaminidasej, and with decreased creatinine clearance (Rosenman et al.
1987). Both of these effects are diagnostic of marginally impaired renal
function. However, the workers in this study were also exposed to cadmium,
which was detected in the urine of 5 of the 27 workers studied. Cadmium is
known to be nephrotoxic; differentiation of the effects of the two metals in
the kidney is not possible with the data presented. Therefore, no conclusion
can be drawn regarding renal effects of silver based on this study.
No studies in animals were located which support the observation of renal
effects in the Rosenman et al (1987) study. Studies in animals have focused
only on the deposition of silver in the kidney following oral exposure (Olcott
1947; 1948) and renal function tests were not conducted.
Dermal/Ocular Effects.  Skin and ocular burns, caused by contact with
silver nitrate, have been reported in workers (Moss et al. 1979; Rosenman et
al 1979).
Granular deposits were observed in the conjunctiva and cornea of the eyes
of 20 out of the 30 workers in the occupational study of Rosenman et al.
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(1979), and subjective determination of the degree of silver deposition in the
conjunctiva correlated with the duration of employment (see also Moss et al.
1979). Furthermore, the amount of deposition in the eyes was found to
correlate significantly with reports of changes in skin color and decreased
night vision. The complaint of decreased night vision was also recorded in a
study of workers involved in the manufacture of metal silver powders (Rosenman
et al. 1987).
An investigation of silver reclamation workers found that 21% and 25%
exhibited conjunctival and cornea1 argyrosis (silver staining or deposition),
respectively (Pifer et al. 1989). Moreover, 74% of the subjects exhibited
some degree of internal nasal-septal pigmentation. However, no association
was observed between silver deposition and ocular impairment.
In another report describing the same cohort of workers as studied by
Rosenman et al. (1979), Moss et al. (1979) conducted electrophysiological and
psychophysiological studies of the eyes of 7 of the 10 workers who had
complained of decreased night vision. No functional deficits were found in
the vision of these workers.
The relative contributions of dermal/ocular absorption, ingestion, and
inhalation of silver compounds to the development of these ocular deposits and
skin color changes are not known. However, granular deposits containing
silver have been observed to-develop in various ocular tissues of animals
following ingestion of silver compounds, and it is likely that systemic
absorption following inhalation exposure also results in silver deposition
(Matuk et al 1981; Olcott 1947; Rungby 1986). The possibility remains that
the deposits were in some proportion caused by direct exposure of the eyes to
airborne silver compounds.
No studies were located regarding dermal or ocular effects in animals
following inhalation exposure to silver or silver compounds.
No studies were located regarding the following health effects in humans
or animals after inhalation exposure to silver or silver compounds.
2.2.1.3 Immunological Effects
2.2.1.4 Neurological Effects
2.2.1.5 Developmental Effects
2.2.1.6 Reproductive Effects
2.2.1.7 Genotoxic Effects
2.2.1.8 Cancer
16
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2.2.2 Oral Exposure
2.2.2.1 Death
No studies were located regarding death in humans following oral exposure
to silver or silver compounds.
Death has been observed in rats following ingestion of colloidal silver
and inorganic silver compounds. In each case the level of silver was very high.
For example, death was reported in rats (number not specified) following acute
oral ingestion of silver colloid (Dequidt et al. 1974). In another study,
Walker (1971) reported deaths in 3 of 12 rats during a 2-week exposure to
silver nitrate in drinking water. Cause of death was not reported in either of
these studies. However, the rats in the Walker (1971) study were observed to
decrease their water intake "precipitously" beginning on the 1st day of
exposure, and survivors were generally described as "poorly groomed and
listless" at the end of the exposure. No lethality occurred in a lower dose
group.
Death was also reported in an unspecified number of rats receiving 222.2mg
silver/kg/day as silver nitrate in drinking water over a longer duration (Matuk
et al. 1981). The deaths began occurring approximately 23 weeks into 37-week
experiment during which the exposed animals also showed a decreased weight gain
compared to animals receiving only water. The highest NOAEL values and all
reliable LOAEL values for death in each species and duration
are recorded in Table 2-l and plotted in Figure 2-l.
2.2.2.2 Systemic Effects
No studies were located regarding respiratory, gastrointestinal,
hematological, musculoskeletal, hepatic, or renal effects in humans or animals
after oral exposure to silver or silver compounds.
Cardiovascular Effects.  No studies were located regarding cardiovascular
effects in humans following oral exposure to silver or silver compounds.
One study reported enlargement of the left ventricle in rats following 9-
29 months of oral exposure to silver nitrate or silver chloride in drinking
water (Olcott 1950). Left ventricle size (expressed as a ratio of ventricle
weight to body weight) increased with exposure,duration, and showed a tendency
to increase with dose of silver. The authors suggest that the increase in
ventricle size could be caused by hypertension, but no blood pressure
measurements were performed. Gross and histopathological examination of the
tissues revealed only a few scattered granular deposits in the heart. The
effect on left ventricle size was seen at a dose of 88.9 mg silver/kg/day;
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however, limitations of the study such as poor experimental design and
inadequate reporting of methods preclude use of these data to predict
equivalent levels of exposure in humans.
Dermal/Ocular Effects.  Gray or blue-gray discoloration of the skin has
been observed in individuals that have ingested both metallic silver and silver
compounds in small doses over periods of months to years. Silver containing
granules have been observed during histopathologic examination of the skin of
these individuals. The condition is termed "argyria."  Unfortunately, only
rough estimates of the amount of silver ingested were located, and therefore
precise levels of exposure resulting in discoloration cannot be established.
Case histories of argyria have been published concerning individuals who
had ingested silver through excessive use of antismoking lozenges containing
silver acetate, silver nitrate solutions for the treatment of gum disease,
breath mints coated with metallic silver, and capsules containing silver
nitrate for the relief of gastrointestinal "discomfort" (Aaseth et al. 1981;
Blumberg and Carey 1934; East et al. 1980; MacIntyre et al 1978; Marshall and
Schneider 1977; Shelton and Goulding 1979; Shimamoto and Shimamoto 1987). In
general, quantitative data were nonexistent or unreliable and could not be used
to establish LOAELs. The only common symptom among these cases was the
resulting gray pigmentation of the skin of primarily sun-exposed regions.
Examination of skin biopsies. from these individuals at the light microscopic
level revealed granular deposits in the dermis. The granules were distributed
throughout the dermis, but were particularly concentrated in basement membrane
and elastic fibers surrounding sweat glands. The granules have been observed to
contain silver (Bleehen et al. 1981; MacIntyre et al. 1978).
Ingestion of silver nitrate and silver chloride will also cause deposition
of silver granules in the skin of animals (Olcott 1948; Walker 1971). However,
skin discoloration in animals following exposure to these silver compounds has
not been studied specifically, and the level of deposition that leads to skin
discoloration in humans cannot be established based on existing animal data.
Granules are also observed in the eyes of rats exposed to silver nitrate in
drinking water at doses that cause general deposition in other tissues (Matuk
et al. 1981; Olcott 1947; Rungby 1986).  The number of deposits in the eyes is
related to the degree of yellow-to-darkgray pigmentation observed at gross
examination, which in turn is related to the duration of exposure.
Other Systemic Effects.  Rats receiving 222.2 mg silver/kg/day in their
drinking water lost weight over a 37 week exposure period. Weight loss first
appeared about 23 weeks into the experiment, and the authors observed that
several animals that lost weight rapidly died. Body weight in the surviving
experimental animals was an average of 50% less than that of control rats
20
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drinking only distilled water over the same exposure period (Matuk et al.
1981).
2.2.2.3 Immunological Effects
No studies were located regarding immunological effects in humans or
animals following oral exposure to silver or silver compounds.
2.2.2.4 Neurological Effects
Several reports describe the deposition of what are assumed to be
silvercontaining granules in tissues of the central nervous system. One report
describes such granules in certain areas of the brain of an argyric woman at
autopsy (Landas et al. 1985) who had used nose drops containing silver nitrate
(concentration not specified) for an unspecified duration. The areas of the
brain described as containing silver in the Landas et al (1985) study are known
to have more direct exposure to blood-borne agents than other areas (e.g., the
"circumventricular organslt, and the paraventricular and supraoptic nuclei of
the hypothalamus). Unfortunately, the study examines only these specialized
areas, and so does not provide complete information on the distribution of
silver throughout the brain. There is no evidence that clearly relates the
existence or deposition of these granules to a neurotoxic effect of silver
exposure.
However, one study has found that 20 female mice exposed to silver nitrate
in drinking water for 4 months, and observed to have such deposits in the
central nervous system, were less active (hypoactive) than unexposed controls
(Rungby and Danscher 1984). Activity was easured using a blind assay. The
highest concentration of granular deposits occurred in certain areas involved
in motor control (i.e., red nucleus, deep cerebellar nuclei, and motor nuclei
of the brainstem), with lesser amounts observed in the basal ganglia, the
anterior olfactory nucleus, and in the cortex in general. A specific
relationship between the deposition of granules in these brain areas following
silver ingestion and the decrease in gross activity has not been established.
The highest NOAEL values and all reliable LOAEL values for neurological effects
in each species and duration are recorded in Table 2-l and plotted in Figure 2-
1.
2.2.2.5 Developmental Effects
No studies were located regarding developmental effects in humans or
animals after oral exposure to silver or silver compounds.
2.2.2.6 Reproductive Effects
No studies were located regarding reproductive effects in humans after
oral exposure to silver or silver compounds.
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No diminution of fertility was observed in male rats exposed,. for up to
2 years, to 88.9 mg silver/kg/day as silver nitrate or silver chloride in
drinking water (Olcott 1948). Appearance of spermatozoa was normal, and no
silver deposits were observed in the testes. Unfortunately, poor experimental
design and reporting of methods preclude use of these data in determining a no
effect level for male reproductive effects.
2.2.2.7 Genotoxic Effects
No studies were located regarding genotoxic effects in humans or animals
after oral exposure to silver or silver compounds.
2.2.2.8 Cancer
No studies were located regarding cancer in humans or animals after oral
exposure to silver or silver compounds.
2.2.3 Dermal Exposure
2.2.3.1 Death
No studies were located regarding death in humans following dermal
exposure to silver or silver compounds.
Mortality following dermal application of silver nitrate has been
investigated in guinea pigs (Wahlberg 1965). The investigators applied 2.0 mL
of a 0.239 molar solution of silver nitrate, in water by skin depot to 3.1 cm2
of skin for 8 weeks. No deaths were recorded; however, during the exposure
period the guinea pigs ceased to gain weight. In concurrent investigations of
equimolar amounts of other metal salts using the same methods, mercuric
chloride and cobalt chloride caused the death of more than half of the test
animals.
The NOAEL value for death is recorded in Table 2-2.
2.2.3.2 Systemic Effects
No studies were located regarding respiratory, cardiovascular,
gastrointestinal, hematological, musculoskeletal, hepatic, renal, or ocular
effects in humans or animals after dermal exposure to silver or silver
compounds.
Dermal. Medical case histories indicate that dermal exposure to silver or
silver compounds for extended periods of time can lead to local skin
discoloration similar in nature to the generalized pigmentation seen after
repeated oral exposure. However, the amount of silver and the duration of time
required to produce this effect cannot be established with the existing
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information (Buckley 1963; McMahon and Bergfeld 1983). Moreover, adverse
effects such as argyria have not been associated with the use of silver
sulphadiazine as a bactericidal agent (Fox et al. 1969). No studies were
located regarding dermal effects in animals after dermal exposure to silver or
silver compounds.
Other Systemic Effects.  Decreased body weight gain was observed in
guinea pigs following application of 81 mg silver nitrate (2 mL of a 0.239 M
solution) to 3.1 cm2 of skin. At the end of 8 weeks, the silver nitrate-exposed
guinea pigs weighed approximately 10-20% less than unexposed controls and
controls exposed to distilled water (Wahlberg 1965).
2.2.3.3 Immunological Effects
Medical case histories describe mild allergic responses attributed to
repeated dermal contact with silver and silver compounds (Catsakis and Sulica
1978; Hey1 1979; Marks 1966). Sensitization occurred in response to contact
with powdered silver cyanide, radiographic processing solutions, and apparently
to silver in dental amalgam. The duration of exposure ranged from 6 months in a
worker exposed to silver cyanide, 10 years for a woman employed as a radiograph
processor, to 20 years for a woman whose allergy had apparently been caused by
dental fillings. The concentration of silver that caused these allergic
responses is not known. No studies were located' regarding immunological
effects in animals after dermal exposure to silver or silver compounds.
No studies were located regarding the following health effects in humans
and animals after dermal exposure to silver or silver compounds.
2.2.3.4 Neurological Effects
2.2.3.5 Developmental Effects
2.2.3.6 Reproductive Effects
2.2.3.7 Genotoxic Effects
2.2.3.8 Cancer
2.3 TOXICOKINETICS
2.3.1 Absorption
2.3.1.1 Inhalation Exposure
Studies in humans regarding the absorption of silver following inhalation
exposure are limited to occupational studies and a case study. It is assumed
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that the predominant routes of exposure to silver in the workplace are
inhalation and dermal, with the dermal route being more important when
prolonged contact with silver in solution occurs (as in photographic
processing). Given this assumption, existing studies suggest that silver and
silver compounds can be absorbed when inhaled, although the degree of
absorption, both absolute and relative to the degree of dermal absorption, is
not known.
A case study involving an accidental exposure of one worker to
radiolabeled silver metal during a nuclear reactor mishap supports the
assumption that absorption of silver metal dust can occur following inhalation
exposure (Newton and Holmes 1966). Radioactive silver was measured using whole-
body gamma-ray spectrometry beginning two days after a one-time inhalation
exposure and continued for up to 200 days. Localization of silver in the liver,
and detection in feces indicated that passage through the lungs had occurred.
Unfortunately this study did not measure exposure, and therefore absorption
could not be quantitated.
Twelve out of 30 workers in a chemical manufacturing facility which
produced silver nitrate and silver oxide were found to have blood silver levels
greater than the detection limit of 0.6 µg silver/100 mL blood (Rosenman et al.
1979). Exposure levels were estimated to range from 0.039 to 0.378 mg
silver/m3. DiVincenzo et al. (1985) examined the silver content of
blood, urine, and feces of workers exposed to TWA levels of 0.001 to 0.1 mg/m3
insoluble silver in a photographic materials manufacturing facility. The
identity of the specific silver compounds to which the workers were exposed was
not reported. In exposed workers, silver was detected in 80% of the blood
samples and in 100% of the fecal samples (mean concentrations of 0.011 µg/ml
and 15 µg/g, respectively). Silver was detected in 2 of 35 (6%) urine samples
from exposed workers with a mean concentration of 0.009 µg/g. Silver was also
detected in the feces of controls (not exposed occupationally) at a mean
concentration of 1.5 µg/g.  Although these studies suggests that silver
compounds are absorbed from the lungs, unknown exposure levels and lack of
compound identification prevent estimation of extent or rate.
A study in dogs indicates that absorption of inhaled metallic silver
particles with a median aerodynamic diameter of approximately 0.5 µm is
extensive, and is not dependent upon particle size (Phalen and Morrow 1973).
Absorption was measured in one dog that remained anesthetized during the entire
period between exposure and sacrifice. In this dog, 3.1% (0.8 µg) of the
deposited material was dissolved, transported out of the lungs, and was found
mostly in liver and blood 6 hours after exposure; a 1 µg/cm2/day absorption rate
for metallic silver was estimated by the authors. up to 90% of the deposited
silver was estimated to be absorbed into the systemic circulation based on all
experimental data. Clearance from the lung to the blood was triphasic, with
half-lives of 1.7, 8.4, and 40 days.
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2.3.1.2 Oral Exposure
Based on medical case studies and experimental evidence in humans, many
silver compounds, including silver salts and silver-protein colloids, are known
to be absorbed by humans across mucous membranes in the mouth and nasal
passages, and following ingestion. Absorption of silver acetate occurred
following ingestion of a 0.08 mg/kg/day dose of silver acetate containing
radiolabeled silver (110mAg). Approximately 21% of the dose was retained in
the body at 1 week (East et al. 1980; MacIntyre et al. 1978). Furthermore, the
occurrence of generalized argyria in a woman who repeatedly applied silver
nitrate solution to her gums (Marshall and Schneider 1977) suggests that
absorption across the oral mucosa can occur. Information concerning the rate of
oral absorption in humans was not located.
The extent of absorption of an administered dose has been found to be
associated with transit time through the gastrointestinal tract; the authors
report that this may explain some of the interspecies differences in silver
retention observed 1 week after exposure (see Table 2-3). The faster the
transit time, the less silver is absorbed (Furchner et al. 1968). Transit times
vary from about 8 hours in the mouse and rat to approximately 24 hours in the
monkey, dog, and human (Furchner et al. 1968).
2.3.1.3 Dermal Exposure
Several silver compounds appear to be absorbed through the intact skin of
humans, although the degree of absorption is thought to be low. For example,
silver thiosulfate penetrated the intact skin of a photochemical worker via the
eccrine sweat glands and deposited in the dermis, leading to the development of
localized argyria within 6 months of exposure (Buckley 1963).  Silver compounds
also are absorbed through the damaged skin of humans. Silver was detected in
the urine, blood, and body tissues of humans with seriously burned skin
following treatment with topical preparations containing 0.5% silver nitrate to
prevent bacterial infection (Bader 1966). The levels of silver found in one of
the individuals studied by Bader (1966) were 0.038 and 0.12 ppm for urine and
blood, respectively, and ranged from below detection in lung and brain to 1,250
ppm in skin. Snyder et al. (1975) estimated that less than 1% of dermally-
applied silver compounds are absorbed through the intact skin of humans.
Absorption of silver nitrate across intact skin has been demonstrated in
guinea pigs and is similar to that of intact human skin (Wahlberg 1965). The
amount absorbed was estimated to be approximately 1% of the applied dose within
5 hours of exposure. Silver administered in the form of silver sulphadiazine
cream was minimally absorbed through both the intact and burned
skin of rats and distributed throughout the body (Sano et al. 1982). The
absorption of silver increased through burned skin after blister removal. The
authors did not determine the percentage of the applied dose that was absorbed
(Sano et al. 1982).
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2.3.2 Distribution
2.3.2.1 Inhalation Exposure
Limited information was located concerning the distribution of silver in
humans following inhalation of elemental silver or silver compounds. Using
whole-body spectrometer measurements obtained from a person accidently exposed
to radiolabeled silver, Newton and Holmes (1966) estimated that 25% of the
detectable 110mAg was distributed to the liver between 2 and 6 days after
exposure.
Phalen and Morrow (1973) reported that 96.9%, 2.4%, and 0.35% of the dose
initially deposited in the lungs of a dog following intratracheal
administration was detected in the lungs, liver, and blood, respectively, 6
hours after exposure. The remaining silver was detected in the gall bladder and
bile (0.14%), intestines (0.10%), kidneys (0.06%), and stomach (0.02%).
The distribution of metallic silver (expressed as a percentage of the initial
amount deposited) 225 days after exposure differed from that at 6 hours, with
the majority of the metal detected in the liver (0.49%), brain (0.035%), gall
bladder and bile (0.034%), intestines (0.028%), lungs and trachea (0.019%),
bone (0.014%), stomach and contents (0.012%), heart (0.009%), and muscle
(0.007%). The distribution to tissues other than the lungs is similar at 6
hours and 225 days if silver in the lungs is not considered. At both time
points the majority of the silver is found in the liver (approximately 77% of
the total body silver excluding lung content).
2.3.2.2 Oral Exposure
The distribution of silver to various body tissues depends upon the route
and quantity of silver administered and its chemical form. An oral dose of
silver, following absorption, undergoes a first pass effect through the liver
resulting in excretion into the bile, thereby reducing systemic distribution to
body tissues (Furchner et al. 1968). The subsequent distribution of the
remaining silver is similar to the distribution of silver absorbed following
exposure by the inhalation and dermal routes and following intramuscular or
intravenous injection.
Silver distributes widely in the rat following ingestion of silver
chloride (in the presence of sodium thiosulfate) and silver nitrate in drinking
water (at 88.9 mg silver/kg/day for silver nitrate) (Olcott 1948); The amount
of silver in the various tissues was not measured, although qualitative
descriptions of the degree of pigmentation were made. High concentrations were
observed in the tissues of the reticuloendothelial system in the liver, spleen,
bone marrow, lymph nodes, skin, and kidney. Silver was also distributed to
other tissues including the tongue, teeth, salivary glands, thyroid,
parathyroid, heart, pancreas, gastrointestinal tract, adrenal glands, and
brain. Within these tissues advanced accumulation of silver
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particles was found in the basement membrane of the glomeruli, the walls of
blood vessels between the kidney tubules, the portal vein and other parts of
the liver, the choroid plexus of the brain, the choroid layer of the eye, and
in the thyroid gland (Olcott 1948; Moffat and Creasey 1972; Walker 1971).
Approximately 18-19% of a single oral dose of silver acetate was retained
in the body of a human 8-30 weeks after exposure (East et al. 1980; Macintyre
et al. 1978). This amount is 10% greater than that retained in dog tissues 20
weeks after a single oral dose (Furchner et al. 1968).
2.3.2.3 Dermal Exposure
Following the topical application of silver nitrate for the treatment of
burns in two humans, silver was distributed to the muscles (0.03-2.3 ppm),
liver (0.44 ppm), spleen (0.23 ppm), kidney (0.14 ppm), heart (0.032-0.04 ppm),
and bones (0.025 ppm) (Bader 1966). No studies were located that quantitated
the distribution of silver in animals following dermal exposure to silver or
its compounds. However, Sano et al. (1982) detected silver in the
same tissues of rats following topical application of silver sulphadiazine
cream.
2.3.2.4 Other Routes of Exposure
In rats, silver was unevenly distributed in organs and tissues following
intravenous or intramuscular injection of radiolabeled metallic silver and/or
silver nitrate, respectively. The highest concentrations were found, in
decreasing order, in the gastrointestinal tract, liver, blood, kidney, muscle,
bone, and skin following intramuscular injection (Scott and Hamilton 1950).
Following intravenous injection the highest concentrations were found, in
decreasing order, in the liver, pancreas, spleen, and plasma (Klaassen 1979a).
As is shown in Table 2-4, the proportion of the dose distributed to the tissues
is positively correlated with the dose administered (Scott and
Hamilton 1950).
Silver is cleared from the system via the liver (Furchner et al. 1968;
Scott and Hamilton 1950). Deposition of uncleared silver can occur along the
renal glomerular basement membrane (Creasey and Moffat 1973; Danscher 1981; Ham
and Tange 1972; Moffat and Creasey 1972) and mesangium (Day et al. 1976), and
in the Kupffer cells and the sinusoid endothelium cells of the liver (Danscher
1981). Silver has also been detected intra- and extracellularly in the skin and
mucosa of the tongue, in the chromaffin cells, cells of the zona glomerulosa,
and zona fasciculata of the adrenal glands, and in the exocrine and endocrine
sections of the pancreas (Danscher 1981).
In rodents, silver has been shown to cross the placenta and to enter the
fetuses following an intraperitoneal injection of silver lactate to the mothers
(Rungby and Danscher 1983a). Silver was detected in the liver and brain tissues
of rat fetuses (Danscher 1981; Rungby and Danscher 1983a).
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2.3.3 Metabolism
The deposition of silver in tissues is the result of the precipitation of
insoluble silver salts, such as silver chloride and silver phosphate. These
insoluble silver salts appear to be transformed into soluble silver sulfide
albuminates, to bind to or form complexes with amino or carboxyl groups in RNA,
DNA, and proteins, or to be reduced to metallic silver by ascorbic acid or
catecholamines (Danscher 1981). The blue or gray discoloration of skin exposed
to ultraviolet light in humans with argyria may be caused by the photoreduction
of silver chloride to metallic silver. The metallic silver is then oxidized by
tissue and bound as black silver sulfide (Danscher 1981).  Buckley et al.
(1965) identified silver particles deposited in the dermis of a
woman with localized argyria as being composed of silver sulfide.
In rats, silver deposits in internal organs such as the kidney, have also
been identified as the sulfide (Berry and Galle 1982). Under conditions of
exposure to high doses of selenium, the sulfur can be replaced by selenium
(Berry and Galle 1982). The deposition of silver in the kidney was increased
under conditions of high selenium exposure. This may be important in the
development of argyria in people exposed to silver who ingest foods that
contain large amounts of selenium (See Section 2.7).
2.3.4 Excretion
2.3.4.1 Inhalation Exposure
The clearance of radioactive silver metal dust in a man who was
accidentally exposed illustrated the rapid removal of silver from the lungs
primarily by ciliary action, with subsequent ingestion and ultimate elimination
in the feces (Newton and Holmes 1966). Lung clearance fit a biexponential
profile, with biological half-lives of 1 and 52 days.  Radioactive silver was
detected in the feces up to 300 days after exposure, but was not detected in
urine samples (collected up to 54 days after exposure).
Chronic exposure of workers to unidentified silver compounds resulted in
the detection of silver in 100% of the fecal samples and 6% of the urine
samples (DiVincenzo et al. 1985). This occupational exposure is assumed to have
occurred primarily by the inhalation route.
In dogs, lung clearance of metallic silver particles (average aerodynamic
diameter of 0.5µ) following intra-tracheal intubation was accompanied by an
increase in silver concentration in the area of the stomach and liver. The
increase in silver concentration in the stomach suggests that some proportion
of the silver particles are cleared by the mucociliary escalator and swallowed.
However, the predominant route of clearance from the lung appeared
to be through dissolution of the silver and transport through the blood. The
31
31
2. HEALTH EFFECTS
silver was apparently carried by the blood to the liver, with little cleared
via the mucociliary passages (Phalen and Morrow 1973). Approximately 90% of the
inhaled dose was excreted in the feces within 30 days of exposure.  Clearance
of deposited silver particles from the lung fit a triexponential profile, with
biological half-lives of 1.7, 8.4, and 40 days, accounting for 59, 39, and 2%
of the radioactivity excreted, respectively. Clearance of absorbed silver from
the liver fit a biexponential profile with biological half-lives of 9.0 and 40
days accounting for 97% and 3% of the radioactivity excreted, respectively
(Phalen and Morrow 1973).
2.3.4.2 Oral Exposure
Following oral exposure to silver acetate in humans, silver is eliminated
primarily in the feces, with only minor amounts eliminated in the urine (East
et al. 1980). The rate of excretion is most rapid within the first week after a
single oral exposure (East et al. 1980). Whole-body retention studies in mice
and monkeys following oral dosing with radiolabeled silver nitrate
indicate that silver excretion in these species follows a biexponential profile
with biological half-lives of 0.1 and 1.6 days in mice and 0.3 and 3 days in
monkeys. In similarly exposed rats and dogs, silver excretion followed a
triexponential profile with biological half-lives of 0.1, 0.7, and
5.9 days in rats and 0.1, 7.6, and 33.8 days in dogs (Furchner et al. 1968).
Data for whole body clearance of silver at two days after exposure for these
four species are presented in Table 2-5 (Furchner et al. 1968). Transit time
through the gut may explain some of these interspecies differences in silver
excretion. Transit time is approximately 8 hours in mice and rats, and
approximately 24 hours in dogs and monkeys (Furchner et al. 1968). Animals
excrete from 90% to 99% of an administered oral dose of silver in the feces
within 2 to 4 days of dosing (Furchner et al. 1968; Jones and Bailey 1974;
Scott and Hamilton 1950). Excretion in the feces is decreased and deposition in
tissues, such as the pancreas, gastrointestinal tract, and thyroid, is
increased when saturation of the elimination pathway in the liver occurs as a
result of chronic or high level acute exposure to silver (see Table 2-4)
(Constable et al. 1967; Olcott 1948; Scott and Hamilton 1950).
2.3.4.3 Dermal Exposure
No studies were located concerning the excretion of silver by humans or
animals following dermal exposure to elemental silver or silver compounds.
Once absorption through the skin and distribution to bodily tissues occurs, it
can be expected that elimination would be similar to that of silver absorbed
via oral or inhalation exposure, that is, primarily via the feces, with
minimal amounts excreted in the urine.
2.3.4.4 Other Routes of Exposure
Whole body retention studies in mice, rats, monkeys, and dogs following
intravenous injection of radiolabeled silver nitrate indicate that silver
32
2. HEALTH EFFECTS
excretion in these species follows a triexponential profile. (Furchner et al.
1968). For mice and monkeys, this differs from the biexponential profile seen
following oral exposure. Whole body clearance following intravenous exposure
was slower than clearance following oral exposure in each of the four species
observed. In addition, the difference in clearance rate between species was
more dramatic. Clearance at 2 days post-exposure ranged from 15% in the dog to
82% in the mouse (see Table 2-5) (Furchner et al. 1968).
Silver removal from the liver by biliary excretion was demonstrated by
Scott and Hamilton (1950). Control rats and rats with ligated bile ducts were
administered radioactive metallic silver by intramuscular injection. In rats
with ligated bile ducts, excretion of silver in the feces was 19%, compared to
97% in controls. Deposition in the liver of rats with ligated bile ducts was
48% and 2.5% in the gastrointestinal tract compared to 0.36% and 1.12%,
respectively in the controls (Scott and Hamilton 1950). Klaassen (1979b)
determined that biliary excretion accounted for between 24% and 45% of the
silver administered to rats. The concentration of silver in the bile was
estimated to be between 16 and 20 times greater than that in plasma. An
increase in the bile/liver tissue ratio (µg/ml per µg/g) from 4.2 to 6.4
indicates that more silver is concentrated in the bile as the dose of silver
increases. It is believed that active transport is involved in the transfer of
silver from the plasma to the bile (Klaassen 1979b). There are apparently
interspecies differences in this transport process. The variability in the
extent of biliary silver excretion appears to be related to the ability of the
liver to excrete silver into the bile, not to the ability of the silver to pass
between the plasma and the liver. Rats excreted silver in the bile at 10 times
the rate of rabbits. Dogs excreted silver in the bile at a rate lower than that
of rabbits (Klaassen 1979b). Dogs had the highest amount of silver retained in
the liver (2.9 µg silver/g), as compared to the rabbit (2.13 ,µg silver/g) and
rat (1.24 µg silver/g).
2.4 RELEVANCE TO PUBLIC HEALTH
The one clinical condition that is known in humans to be attributable to
long-term exposure to silver and silver compounds is a gray or blue-gray
discoloring of the skin (argyria). Argyria may occur in an area of repeated or
abrasive dermal contact with silver or silver compounds, or more extensively
over widespread areas of skin and the conjunctiva of the eyes
following long-term oral or inhalation exposure. Argyria was common around the
turn of the century when many pharmaceutical preparations contained silver
(Hill et al. 1939). It is much less common today, probably because most current
medications containing silver are for dermal application only. Case reports in
humans have reported that repeated dermal contact with silver
compounds may in some cases lead to contact dermatitis, and a generalized
allergic reaction to silver.
Evidence from both human and animal studies indicates that inhalation of
silver compounds can irritate the respiratory pathway. Occupational studies
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and reports of cases where individuals have accidentally swallowed solutions of
silver nitrate show that both inhalation and ingestion may cause gastric
discomfort as well.
Studies in humans and animals indicate that silver compounds are absorbed
readily by the inhalation and oral routes and poorly by the dermal route, and
are distributed widely throughout the body. Observations made during surgery on
silver exposed individuals and histopathologic studies of animals exposed to
silver compounds demonstrate that within certain tissues of the body (most
notably liver, kidney, pancreas, skin, conjunctiva of the eyes, and, to a
lesser degree, certain brain areas) silver is deposited in the form of granules
visible with the light microscope. However, with the exception of one report of
decreased activity in mice exposed to silver nitrate, and one report of
enlarged hearts in rats exposed to silver nitrate or silver
chloride, there is no evidence that suggests that the silver deposits might
interfere with the normal functioning of these organs in humans.
Death. There is no information concerning death in humans following
exposure to silver compounds by any route.
Data concerning death observed in animals following oral and dermal
exposure to silver compounds suggest that levels of exposure would have to be
quite high to cause death in humans. High levels of colloidal silver were
observed to cause death in rats when administered in drinking water for acute
and intermediate exposure durations. The cause of death was unknown. The
corresponding daily oral dose for a 70-kg man based on the dose levels tested
would be approximately 12 grams. Death caused by silver has not been observed
to occur in humans or animals following dermal exposure to silver compounds,
nor is it expected to occur.
Systemic Effects.  Silver nitrate and/or silver oxide have been reported
to cause upper and lower respiratory tract irritation in humans when inhaled.
In one case, inhalation of an unknown amount and chemical form of silver during
work with molten silver ingots produced respiratory failure the day after
exposure (Forycki et al. 1983). Without treatment the worker may have died.
However, exposures such as this are not expected to be common and should be
examined on a case by case basis.
Upper respiratory irritation has been observed in humans at estimated
exposure levels of between 0.039 and 0.378 mg silver/m3 for less than 1 to
greater than 10 years. Evidence that silver colloid can act as an irritant is
provided by the fact that ultrastructural damage was seen in the tracheal
epithelium of rabbits following inhalation exposure to an unknown concentration
of silver colloid. However, these effects are likely to be related to the
caustic properties of the compounds, not to the presence of silver. The effects
are not expected to persist when exposure to air containing silver compounds
has stopped.
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The same exposure conditions can also cause gastric discomfort in humans.
Again, this effect is likely to be caused by the caustic effects of the silver
compounds, and not the presence of silver. There is no evidence that suggests
that dermal exposure to silver can cause gastric effects.
Occupational exposure to silver compounds has not been observed to affect
blood counts. Although no supportive studies were located regarding
hematological effects in other species or by other routes, the occupational
exposure findings suggest that hematological effects are not a sensitive
indicator of silver toxicity.
Silver is deposited in the glomerular basement membrane of the kidney of
animals, and therefore might be expected to affect renal function. However, no
studies of renal function in animals were located, and occupational studies in
humans are not adequate for establishing a clear relationship between exposure
to silver and renal impairment.
No human studies were located that indicate that exposure to silver or
silver compounds will affect the cardiovascular system. However, an animal
study did show an increase in the relative size of the left ventricle of rats
that had been chronically exposed to silver nitrate or silver chloride in
drinking water. Despite the suggestion by the authors that the increase in left
ventricle size may be caused by vascular hypertension, ‘this effect has not
been observed in animals or in humans. These endpoints have not been
specifically addressed in reliable studies to date.
The predominant effect of exposure to silver in humans is the development
of a characteristic, irreversible pigmentation of the skin. This condition is
called argyria. Clinicians describe the pigmentation as slate-gray, bluegray,
or gray in color and report it as most noticeable in areas of skin exposed to
light. The pigmentation is not a toxic effect per se, nor is it known to be
diagnostic of any other toxic effect. However, the change in skin color can be
severe enough to be considered a cosmetic disfigurement in some cases.
The discoloring is likely to be caused by the photoreduction of silver
chloride and/or silver phosphate in the skin. X-ray dispersive analysis of skin
and other tissues reveals that the granules consist of silver complexed with
sulfur and/or selenium. The photoreduced deposits are not removed by the body,
and there are no clinical means of removing them.
Levels of silver exposure that have led to argyria in humans in the past
are poorly documented, and it is not possible to establish minimum risk levels
for this effect based on these data. Hill and Pillsbury (1939) in their review
of cases of argyria report that total doses of silver that have resulted in
argyria can be as low as a total of 1.4 grams of silver (as silver nitrate)
ingested in small unspecified doses over several months.
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An animal model for studying the pigmentation changes seen in humans does
not exist. Therefore existing experimental animal data are of limited use in
predicting the exposure levels that would result in argyria in humans.
Granular deposits that contain silver have been observed in both pigmented and
unpigmented skin of silver-exposed humans. Similar granules have been observed
in various tissues in animals following silver exposure (see Section
2.2 and below). However, a direct correlation has not been established between
the granular deposits seen in animals following exposure to silver and the
deposition leading to skin discoloration in humans.
Immunological Effects.  No studies were located that investigated toxic
effects on the immune system in humans or animals exposed to silver, or that
indicate that immune-related disease can be affected by silver exposure.
Silver has been observed to elicit a mild allergic response (contact
dermatitis) in humans following dermal exposure to various silver compounds.
Neurological Effects.  Neurological effects attributable to silver have
not been reported in humans nor have existing case or occupational studies
focused on this endpoint. Exposure to silver has been observed to result in the
deposit of silver in neurons of the central nervous system of a woman who had
used nasal drops containing silver nitrate and in animals exposed by
intraperitoneal injection and through drinking water. However, this effect is
not known to be toxic. As measured using a controlled, blind assay, the
activity of mice with silver deposits in their brain was less than that of
controls. The decrease in activity could be attributable to other factors
unrelated to central nervous system function (such as loss of appetite due to
gastric effects, or general malaise) and the relevance to humans is not known.
Exposure to silver has been observed to affect the volume of hippocampal
cell groups within the brain of animals. Several cell groups within the
hippocampus (a well defined structure of the brain involved in some aspects of
memory) are reduced in overall volume in rats exposed during their first 4
weeks of life to subcutaneously injected silver lactate (0.137 mg
silver/kg/day) (Rungby et al. 1987). Unfortunately, the study is limited in
that only one small region of the brain was examined. It is prudent to assume
that similar effects would be observed in humans; however, the implications of
the altered volume of these cell groups are not known.
Developmental Effects.  Based on the existing information, it is not known
whether silver causes developmental toxicity in humans. No studies were found
concerning developmental effects in humans after exposure to silver. However, a
human study by Robkin et al. (1973) did investigate the possibility of a
relationship between the concentration of this heavy metal in the tissue of
fetuses and the occurrence of developmental abnormalities.  These authors
reported that the concentration of silver in the fetal liver of 12 anencephalic
human fetuses was higher (0.75±0.15 mg/kg) than the values from 12 fetuses
obtained either through therapeutic abortions
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(0.23±0.05 mg/kg), or in 14 spontaneously aborted fetuses (0.21±0.05 mg/kg).
The concentration in 9 premature infants was 0.68±0.22 mg/kg.  The authors
could not determine if the higher concentrations of silver in anencephalic
fetuses were associated with the malformation, or with fetal age.
Silver has been demonstrated in the brains of neonatal rats whose mothers
received injections of silver lactate on days 18 and 19 of gestation (Rungby
and Danscher 1984). As mentioned above, treatment of neonatal rats has also
been found to reduce the volumes of certain cell groups within the hippocampus
(Rungby et al. 1987). However, functional tests were not performed on these
rats, and therefore, neither the significance of the silver accumulation, nor
the decrease in regional hippocampal volume can be determined.
Reproductive Effects.  The existing evidence does not point to a strong
effect of silver on reproduction. However, no multigeneration reproductive
studies were located, and therefore a firm conclusion regarding reproductive
toxicity can not be made.
There is no historical evidence in humans to suggest that silver affects
reproduction, although studies specifically designed to address this endpoint
in humans were not located. One study in five male rats found that single
subcutaneous injections of 0..04 millimole/kg silver nitrate caused temporary
histopathological damage to testicular tissue (Hoey 1966). Eighteen hours after
a single injection, silver caused shrinkage, edema, and deformation of the
epididymal tubules. All affected tissues showed gradual recovery from damage
following the initial injection, in spite of continued daily injections.
Although treatment over a 30-day period had no effect on spermatogenesis,
spermatozoa were observed with separated and pyknotic heads.  A separate
drinking water study in male rats did not observe changes in spermatozoa or
diminution in fertility.
Finally, direct intrauterine injection of silver nitrate terminated
pregnancies in monkeys (Dubin et al. 1981). Single dose intrauterine injections
of 1% silver nitrate solution (0.78 mg/kg) resulted in vaginal bleeding for 1
or 2 days following treatment. The bleeding lasted for an average of 5.3 days.
Pregnancy was terminated in all these cases. In subsequent pregnancies, these
monkeys produced normal offspring. The relevance of direct uterine injection to
human exposure conditions from NPL site contamination must be evaluated on a
case by case basis since this effect has not been studied by the more common
exposure pathways.
Genotoxic Effects.  No studies were located that examined the mutagenicity
or genotoxicity of silver in human cells in vivo or in vitro.  Existing data on
mutagenicity are inconsistent, but data on genotoxicity suggest that the silver
ion is genotoxic. Table 2-6 presents the results of in vitro genotoxicity
studies using bacteria and nonhuman mammalian cell cultures. From these studies
and others it is evident that the silver ion
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does bind with DNA in solution in vitro, and that it can interact with DNA in
ways that cause DNA strand breaks and affect the fidelity of DNA replication
(Goff and Powers 1975; Loeb et al. 1977; Luk et al. 1975; Mauss et el. 1980;
Robison et al. 1982; Scicchitano and Pegg 1987). However, silver has not been
found to be mutagenic in bacteria (Demerec et al. 1951; Kanematsu et al. 1980;
McCoy and Rosenkranz 1978; Nishioka 1975; Rossman and Molina 1986).
Cancer.  No studies were located regarding cancer in humans following
inhalation, oral, or dermal exposure to silver or silver compounds.
Fibrosarcomas have been induced in rats following subcutaneous imbedding of
silver foil (Oppenheimer et al. 1956). In this study, imbedded silver metal
foils appeared to produce fibrosarcomas earlier (latent period as short as 275
days compared to 364-714 days) and more frequently (32% of implantation sites
compared to O-S%) than other metal foils (steel, tantalum, tin, and vitallium)
tested. However, experiments on several metals (steel, tantalum, and
vitallium) were not complete at the time of publication so adequate comparisons
could not be made. In addition, it should be noted that several material are
known to regularly produce such tumors when implanted subcutaneously in
animals, and the relevance to carcinogenesis in humans is uncertain (Coffin and
Palekar 1985). Both positive (Schmahl and Steinhoff 1960) and negative (Furst
and Schlauder 1977) results for tumorigenesis have been reported following
subcutaneous and intramuscular injection, respectively, of colloidal silver in
rats. However, the relevance of these routes of exposure to exposure conditions
at hazardous waste sites has not been clearly established. Animal toxicity and
human occupational studies using normal routes of exposure have not provided
indications of carcinogenicity, and silver is not expected to be carcinogenic
in humans.
2.5 BIOMARKERS OF EXPOSURE AND EFFECT
Biomarkers are broadly defined as indicators signaling events in biologic
systems or samples. They have been classified as markers of exposure, markers
of effect, and markers of susceptibility (NAS/NRC 1989).
A biomarker of exposure is a xenobiotic substance or its metabolite(s) or
the product of an interaction between a xenobiotic agent and some target
molecule or cell that is measured within a compartment of an organism (NAS/NRC
1989). The preferred biomarkers of exposure are generally the substance itself
or substance-specific metabolites in readily obtainable body fluid or excreta.
However, several factors can confound the use and interpretation of
biomarkers of exposure. The body burden of a substance may be the result of
exposures from more than one source. The substance being measured may be a
metabolite of another xenobiotic (e.g., high urinary levels of phenol can
result from exposure to several different aromatic compounds). Depending on the
properties of the substance (e.g., biologic half-life) and environmental
conditions (e.g., duration and route of exposure), the substance and all of
its metabolites may have left the body by the time biologic samples can be
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taken. It may be difficult to identify individuals exposed to hazardous
substances that are commonly found in body tissues and fluids (e.g., essential
mineral nutrients such as copper, zinc and selenium). Biomarkers of exposure to
silver are discussed in Section 2.5.1.
Biomarkers of effect are defined as any measurable biochemical,
physiologic, or other alteration within an organism that, depending on
magnitude, can be recognized as an established or potential health impairment
or disease (NAS/NRC 1989). This definition encompasses biochemical or cellular
signals of tissue dysfunction (e.g., increased liver enzyme activity
or pathologic changes in female genital epithelial cells), as well as
physiologic signs of dysfunction such as increased blood pressure or decreased
lung capacity. Note that these markers are often not substance specific.  They
also may not be directly adverse, but can indicate potential health impairment
(e.g., DNA adducts). Biomarkers of effects caused by silver are discussed in
Section 2.5.2.
A biomarker of susceptibility is an indicator of an inherent or acquired
limitation of an organism's ability to respond to the challenge of exposure to
a specific xenobiotic. It can be an intrinsic genetic or other characteristic
or a preexisting disease that results in an increase in absorbed dose,
biologically effective dose, or target tissue response. If biomarkers of
susceptibility e xist, they are discussed in Section 2.7, "POPULATIONS THAT ARE
UNUSUALLY SUSCEPTIBLE."
2.5.1 Biomarkers Used to Identify or Quantify Exposure to Silver
Silver can be detected in blood, urine, feces, hair, and biopsy specimens
using standard analytic techniques, as well as whole body analysis using in
vivo neutron activation. The presence of silver in these samples can be used,
with varying degrees of accuracy depending on the sample, as a biomarker of
exposure to silver compounds. Analysis of hair has been used to monitor for
silver exposure (DiVincenzo et al. 1985). However, silver can be adsorbed onto
hair surfaces as well as deposited during hair formation, and since current
testing procedures cannot differentiate between the two modes, hair monitoring
is an unreliable biomarker of exposure (DiVincenzo et al. 1985).  Levels of
silver in feces, blood, and urine have been associated with recent
exposure via inhalation, oral, and dermal routes. Levels in these biological
media may serve as more reliable, primary biomarkers of exposure to silver than
levels in hair (DiVincenzo et al. 1985; Rosenman et al. 1979, 1987).  These
biomarkers appear to be independent of the route of exposure, but have not been
quantitatively correlated with level and duration of exposure. The
prevalence and estimated magnitude of silver deposition in the skin, however,
were associated with duration of occupational exposure.
Because silver is eliminated primarily through the feces, recent exposure
is most easily monitored through fecal analysis. Measurements of silver in the
blood are also significant and indicate exposure to the metal. However,
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silver is not always detected in the urine samples of workers with known
exposure to the chemical, and is not as reliable a biomarker as feces and
blood. DiVincenzo et al. (1985), for example, detected silver in 100% of feces
samples and only 6% of urine samples from workers chronically exposed to silver
compounds in air. Increased blood silver levels, above the detection limit for
silver (0.6 µg/l00 mL blood), have been associated with inhalation exposure to
the metal in a study by Rosenman et al. (1979).
Levels in biopsy specimens (e.g., of skin) provide information concerning
repeated exposure (Blumberg and Carey 1934; East et al. 1980). After a burn
victim had been dermally exposed to silver nitrate (as a bactericidal agent),
Bader (1966) found silver primarily in the patient's skin as well as in the
blood and urine. Further information can be found in Section 2.3.
2.5.2 Biomarkers Used to Characterize Effects Caused by Silver
Several effects associated with silver exposure have been reported in
humans which may be useful as biomarkers of effects. The significance of these
biomarkers, however, is in doubt, because they do not appear consistently in
exposed individuals and do not seem to correlate well with levels and duration
of exposure.
One easily observed effect of silver exposure is argyria which is a slate-
gray or blue-gray discoloration of the conjunctivae, cornea, skin, and other
epithelial surfaces. Oral, inhalation, or dermal absorption of silver may cause
argyria in humans. A potential biomarker of silver deposition that could lead
to this effect would be the presence of insoluble silver salts
(e.g., silver chloride, sulfide, or phosphate) in skin biopsy, especially that
associated with basement membrane (Danscher 1981). The granular deposition of
silver in the cornea of workers has been loosely associated with complaints of
decreas.ed night vision (Moss et al. 1979; Rosenman et al. 1979). However,
Pifer et al. (1989) studied various ophthalmological end points in workers
exposed to silver and silver compounds and could find no significant ocular
impairments associated with the metal.
Low oxygen content in capillary blood, scattered thickening of lungs (as
observed in chest radiograms), and upper respiratory irritation have been
observed in studies of workers exposed intensely or chronically to molten
silver or silver dusts (Forycki et al. 1983; Rosenman et al. 1979, 1987).
Inhalation exposure also led to decreased red blood cell count and an
increased mean corpuscular volume (Pifer et al. 1989). However, these potential
hematologic biomarkers are not specific for silver exposure, and do not
indicate or predict significant clinical sequelae.
Rosenman et al. (1987) found that inhalation exposure to silver caused
changes in two renal end points which could be biomarkers of mild
nephrotoxicity. In this study exposed workers exhibited lower creatinine
clearance and higher excretion of the urinary enzyme N-acetyl-β-D
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glucoseaminidase. However, workers in the study were also exposed to cadmium,
a known nephrotoxic agent, which may have been responsible for the observed
changes. Therefore, these biochemical effects cannot be considered reliable
biomarkers of silver exposure. Occupational exposure to silver nitrate and
silver oxide, leading to blood silver levels above 0.6 µg/100 mL, correlated
strongly with increased complaints of abdominal pain (Rosenman et al. 1979).
Moreover, dermal exposure to silver and silver compounds has been associated
with a mild allergic reaction in humans which may be a biomarker of
immunological effects (Catsakis and Sulica 1978; Hey1 1979; Marks 1966).
Please refer to Section 2.2 of Chapter 2 for a more detailed discussion of the
effects caused by silver and its compounds.
2.6 INTERACTIONS WITH OTHER CHEMICALS
As with other metals, relationships exist through which silver can
influence the absorption, distribution, and excretion of one or more other
metals. These influences are not known to increase the toxicity of other
metals, nor are other metals known to add to any toxic effects of silver.
However, high intake of selenium (e.g., as sodium selenite or selenium
oxide) may lead to increased deposition of insoluble silver salts in body
tissues through the formation of silver selenide (Alexander and Aaseth 1981;
Berry and Galle 1982; Nuttall 1987). Exposure to silver nitrate in drinking
water concurrent with intraperitoneal injections of selenium dioxide results
in a higher rate of deposition of granular deposits in the kidneys of rats than
that seen with exposure to silver nitrate alone (Berry and Galle 1982).  Higher
deposition rates are likely to accelerate the development of argyria, although
no data were located to confirm this.
No other studies were located regarding additive or synergistic toxic
interactions of silver with any other substance. However, exposure to moderate-
to-high silver levels (130-1000 ppm) in rats with dietary deficiencies such as
vitamin E alone (Bunyan et al. 1968; Grass0 et al. 1969) or vitamin E and
selenium (Van Vleet 1976; Van Vleet et al. 1981) can cause moderate-to-severe
liver necrosis.
It should be noted that selenium plays a dual role in the toxicity of
silver. On the one hand, it increases the silver deposition rate in body
tissues, which suggests that humans exposed to both high selenium and high
silver may be more likely to develop argyria. On the other hand, a
seleniumdeficient diet combined with high silver intake can cause liver
necrosis.
2.7 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE
Populations that are unusually susceptible to toxic effects of silver
exposure are those that have a dietary deficiency of vitamin E or selenium, or
that may have a genetically based deficiency in the metabolism of these
essential nutrients. Individuals with damaged livers may also be more
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susceptible to the effects of silver exposure. In addition, populations with
high exposures to selenium may be more likely to develop argyria.
Furthermore, some individuals may exhibit an allergic response to silver.
2.8 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, directs the Administrator of ATSDR (in
consultation with the Administrator of EPA and agencies and programs of the
Public Health Service) to assess whether adequate information on the health
effects of silver is available. Where adequate information is not available,
ATSDR, in conjunction with the National Toxicology Program (NTP), is required
to assure the initiation of a program of research designed to determine the
health effects (and techniques for developing methods to determine such health
effects) of silver.
The following categories of possible data needs have been identified by a
joint team of scientists from ATSDR, NTP, and EPA. They are defined as
substance-specific informational needs that, if met would reduce or eliminate
the uncertainties of human health assessment. In the future, the identified
data needs will be evaluated and prioritized, and a substance-specific research
agenda will be proposed.
2.8.1 Existing Information on Health Effects of Silver
The existing data on health effects of inhalation, oral, and dermal
exposure of humans and animals to silver are summarized in Figure 2-2. The
purpose of this figure is to illustrate the existing information concerning the
health effects of silver. Each dot in the figure indicates that one or more
studies provide information associated with that particular effect. The dot
does not imply anything about the quality of the study or studies. Gaps in this
figure should not be interpreted as "data needs" information.
The majority of literature reviewed concerning the health effects of
silver in humans described case reports of individuals who developed argyria
following oral exposure to silver. Occupational studies describing two separate
worker populations were also located. The predominant route of exposure in the
occupational studies is believed to have been inhalation, but
the possibility of some degree of oral or dermal exposure cannot be ruled out.
Information on human exposure is limited in that the possibility of concurrent
exposure to other toxic substances cannot be excluded, and the duration and
level of exposure to silver generally cannot be quantitated from the
information presented in these reports.
As can be seen in Figure 2-2, very little information exists on the
effects of dermal or inhalation exposure to silver in animals. Despite the need
to evaluate NPL site exposure on a case by case basis, these routes are not
expected to be significant sources of silver exposure.  Furthermore, the oral
exposure route has been examined primarily in regards to silver
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deposition in various tissues. The studies were not designed to examine other
end points.
2.8.2 Identification of Data Needs
Acute-Duration Exposure.  Information exists on the effects of
acuteduration inhalation exposures to silver in humans and experimental
animals.  The information located is limited to one case report and an animal
study that examined a single end point. Information concerning acute-duration
exposure by the oral and dermal routes was not located. Insufficient data exist
to establish a target organ or an MRL. Pharmacokinetic data that would support
the identification of target organs across routes for acute-duration exposures
were also not located. A more general data need is a comparative analysis of
the toxicity of various silver compounds. Comparative toxicity data of silver
compounds would allow a more accurate analysis of variations in toxicity caused
by site-specific conditions, as may occur at NPL sites, or oxidizing and
reducing conditions associated with specific exposure routes. Acuteduration
exposure information would be useful because there may be populations adjacent
to hazardous waste sites that might be exposed to silver for brief periods.
Intermediate-Duration Exposure.  Information exists on the effects of
intermediate dose exposures in both humans (inhalation and oral) and
experimental animals (oral only). However, sufficient data do not exist to
identify a target organ or establish an MRL for intermediate exposure
durations. The exact duration and level of exposure in the human studies
generally cannot be quantitated because the information is derived from
anecdotal case reports rather than controlled epidemiological studies.
Moreover, the animal studies predominantly describe deposition in the nervous
system, eyes, and skin. One animal study has implicated the heart as a target
organ. Controlled epidemiological studies in which exposure duration and
level are quantified could be useful in identifying target organs in humans and
for estimating the risk associated with intermediate-duration exposures.
Additional animal studies investigating possible functional changes in organs
in which silver deposition has been observed could also be used to identify
possible health effects in humans. Animal studies that report deposition of
silver in the skin employ intermediate or chronic exposure levels that are well
above those estimated to cause argyria in humans. A reliable animal model of
silver deposition rates and the occurrence of argyria may not be possible
because of the photoreduction role that light plays.and the difficulty in
providing similar conditions for laboratory animals. However, a dose-response
study in which the deposition of silver in the skin is examined would be
helpful in deriving MRLs for the development of argyria.  Pharmacokinetic data
that would support the identification of target organs across routes for
intermediate-duration exposures were also not located.  Little or no reliable
information exists for other end points. Intermediateduration exposure
information would be useful because there may be mobile or
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migratory populations adjacent to hazardous waste sites that might be exposed
to silver for similar durations.
Chronic-Duration Exposure and Cancer.  No controlled epidemiological
studies have been conducted in humans. Although argyria has been known to occur
following chronic silver exposure, the general lack of quantitative information
concerning this effect in humans or animals precludes the derivation of an MRL
for this duration. Occupational studies weakly suggest that impairment of
vision, gastrointestinal distress, or renal histopathology may result from
chronic exposure to silver in humans. Additional information would be useful in
confirming or denying these possibilities, and in establishing an MRL for
chronic exposure. Pharmacokinetic data that would be useful in the
identification of target organs or carcinogenic potential across routes for
chronic duration exposures were also not located. Predominantly
negative genotoxicity studies and the lack of reports of cancer associated with
silver in humans, despite long-standing and varied usage, suggest that silver
does not cause cancer. However, no chronic toxicity/carcinogenicity bioassays
have been conducted in animals, and one study has reported an increase in
tumors in rats following subcutaneous injections (the tumors occurred
predominantly at the site of injection). A combined chronic
toxicity/carcinogenicity study would be useful to address uncertainties in the
database. Chronic-duration exposure information would be useful because there
may be populations adjacent to hazardous waste sites that might be exposed to
silver for long periods of time.
Genotoxicity.  No studies were located that address the genotoxic effects
of silver in humans. All information on silver genotoxicity comes from in vitro
studies (predominantly microbial assays). These studies indicate that, while
silver ions do interact with DNA in vitro, silver is not mutagenic.  However,
there is evidence that silver can cause DNA strand breaks and influence the
fidelity of DNA replication. Better characterization of this evidence of
genotoxicity, especially in in vivo test systems, would assist in the
evaluation of silver genotoxicity.
Reproductive Toxicity.  No information on the reproductive effects of
silver in humans was located. Limited information in one study in laboratory
animals suggests that chronic oral exposure to levels of silver high enough to
cause widespread granular deposition has a low potential to induce adverse
reproductive effects in either sex. However, this study did not examine all
relevant reproductive end points. Furthermore, no studies were located that
examined reproductive effects following silver exposure by inhalation or dermal
routes. One subcutaneous injection study in animals demonstrated an effect on
testicular tissue and sperm morphology (Hoey 1966). Examination of reproductive
pathology in a go-day study would be useful to determine whether or not a
multigeneration reproductive study is warranted to clarify the issue of
reproductive effects of silver.
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Developmental Toxicity.  No information concerning developmental effects
of silver in humans resulting from ingestion, inhalation, or dermal contact
with silver was found. One study did investigate the relationship between
silver levels in fetal tissue and the occurrence of deformities. However, a
causal relationship was not established between exposure to silver and the
deformities. Limited data in neonatal rats indicate that silver in drinking
water can reduce the volume of certain well-defined brain regions. However, the
functional significance of changes in volume of these small brain areas is not
known. Data from pharmacokinetic studies that would support cross-route
extrapolation were not located. Studies that further investigate the above
end points for all routes of exposure would be useful to characterize the
developmental effects of silver.
Immunotoxicity.  Information on immunological effects of silver in humans
is limited to clinical observations of allergic reactions to silver compounds
after repeated dermal exposure in humans. No animal studies were located that
examine immunologic end points, or that provide additional information
regarding the allergic response to the silver ion. Information concerning the
allergic potential of silver by the dermal, oral, and inhalation routes would
be useful in identifying potential sensitive populations. A battery of immune
function tests (e.g., ratio of T cells to B lymphocytes, levels of antibody
classes, macrophage function, etc.) would be useful to determine whether silver
compounds adversely affect the immune system.
Neurotoxicity.  Existing studies show that silver can be deposited in
anatomically defined regions of the brain .in both humans and animals following
repeated oral exposure to silver. Other studies indicate that neuroanatomical
changes can occur in young rats, and that the general activity level of exposed
mice is less than that of unexposed mice. The significance of the
neuroanatomical changes is not clear, and the study investigated only one small
area that was not reported as an area of high silver deposition.  Studies of
the neuroanatomical areas that concentrate silver, and more specific
neurobehavioral tests, would assist in defining the neurotoxic potential of
silver for all routes of exposure.
Epidemiological and Human Dosimetry Studies.  Most of the existing
information on the effects of silver in humans comes from cases of individuals
diagnosed with argyria following the intentional ingestion of medicinal silver
compounds (silver nitrate and silver acetate) and from exposure of small
numbers of worker populations in chemical manufacturing industries. Inherent
study limitations include unquantified exposure concentrations and durations,
as well as possible concomitant exposure to other toxic substances.
Wellcontrolled epidemiological studies of communities living in close proximity
to areas where higher than background levels of silver have been detected in
soil and surface and/or groundwater, such as might occur near hazardous waste
sites, and occupationally exposed groups would help supply information needed
to clarify speculation regarding human health effects caused by silver.
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Biomarkers of Exposure and Effect.  Silver can be detected in blood,
urine, feces, hair, and skin biopsy specimens. The best indictor of recent
exposure to silver or silver compounds is detection of silver levels in feces
and blood. Intermediate as well as long-term exposures are best monitored by
measuring silver in blood or skin biopsy specimens. Argyria, the change in skin
color associated with silver exposure, is also an indicator of chronic
exposure. No other biomarkers for silver have been developed. Development of
alternative biomarkers capable of detecting early exposure to low levels of
silver would be useful in determining the possible toxic effects of this metal.
The only biomarkers of effect that have been reliably associated with
silver exposure are argyria and granular deposits in the dermis and eyes.
These are normally observed only in cases of intermediate and long-term
exposure. Some clinical symptoms (e.g., gastrointestinal distress and
respiratory discomfort) have been loosely associated with exposure, but are not
definitive for exposure. No good quantitative correlations have been drawn
between body levels of silver and these observed effects. Development of
additional biomarkers of effect, especially for short-term and low-level silver
exposure would be useful in determining the potential of silver to cause health
impairment or disease. More information on the body burden of individuals with
argyria, including skin biopsies, would help clinicians determine the risk of
argyria for individuals with a history of silver exposure. If exposure levels
of silver can be shown to correlate with specific adverse health effects, it
may be possible to determine quantitative relationships between changes in
tissue and/or body levels of silver.
Absorption, Distribution, Metabolism, and Excretion.  The database for
inhalation and dermal absorption of silver compounds in humans consists
primarily of qualitative evidence from occupational case studies. Limited
quantitative information exists on the oral absorption of silver compounds in
humans. Research into the quantitative absorption of various silver compounds
following relevant exposure routes would be useful to better predict the
potential for toxic responses to particular silver compounds in humans.
Additional research into the comparative absorption, distribution,
metabolism, and excretion of different silver compounds would allow a more
accurate determination of the effects of silver exposure under specific
environmental conditions. The current database primarily provides information
concerning silver nitrate. Certain compounds that may exist at hazardous
waste sites, such as silver oxide, silver thiosulfate, silver chloride, silver
phosphate, and silver sulfide, have not been studied.
Studies were located for oral and dermal absorption in animals, but are
lacking for absorption from inhalation exposure. Additional animal data would
be useful in predicting the rate and extent of the inhalation absorption of
various silver compounds in humans.
49
2. HEALTH EFFECTS
The only information that exists regarding distribution of silver in
humans comes from an accidental exposure to an unknown quantity of radiolabeled
silver metal dust. The distribution of various silver compounds is known in
animals following inhalation and intravenous exposure; only qualitative
information exists for oral or dermal exposure. Quantitative data on the
distribution of various silver compounds following oral and dermal exposure
would be useful when predicting the distribution of silver following exposure
to specific silver compounds in humans.
There are data to assess the metabolic fate of silver compounds in humans
and animals. Additional studies may shed light on possible variation in
susceptibility to silver-related toxic effects. Elucidating the mechanism by
which silver exerts toxicity in mammalian cells would assist in evaluating how
this affects the health of the whole organism.
The kinetics of the excretion of various silver compounds are well
characterized in animals and limited human data exist for inhalation and oral
exposure. Further study into (1) the underlying basis for observed species
differences; (2) quantitation of the elimination of dermally absorbed silver
compounds; and (3) the basis for observed interpersonal differences in
tolerance would aid in identification of human subpopulations with varying
susceptibilities to the toxic effects of silver.
Comparative Toxicokinetics.  A limited number of studies exist regarding
the comparative toxicokinetics of orally administered silver compounds in rats,
dogs, monkeys, and humans. A more complete comparison of the absorption and
elimination of silver in humans and rats may be warranted given that much of
the toxicokinetic data comes from rats. It would also be useful to acquire data
on the comparative toxicokinetics of various silver compounds in several
species of experimental animals and in humans following inhalation and dermal
exposure in order to model the kinetics of silver deposition across different
exposure scenarios and within sensitive populations.
2.8.3 On-going Studies
No on-going studies were identified that explore the health effects or
toxicokinetics of silver or that attempt to associate silver levels in human
tissues with effects.

51
3. CHEMICAL AND PHYSICAL INFORMATION
3.1 CHEMICAL IDENTITY
The synonyms and identification numbers for silver and selected silver
compounds are listed in Tables 3-1 through 3-6.
3.2 PHYSICAL AND CHEMICAL PROPERTIES
Important physical and chemical properties of silver and selected silver
compounds are given in Tables 3-7 through 3-12.
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4. PRODUCTION, IMPORT, USE AND DISPOSAL
4.1 PRODUCTION
Silver is a rare, but naturally occurring, element. It is often found
deposited as a mineral ore in association with other elements. It is acquired
primarily as a by-product during the retrieval of copper, lead, zinc, and gold
ores (Grayson 1983). The primary silver mines of the United States are located
in the Coeur d'Alene mining district in the northern Idaho panhandle (Smith and
Carson 1977). This area accounts for approximately 71% of domestic mine
production (Drake 1980). It is mined using either open pit or underground
methods, and the ore is then upgraded through a series of processes including
flotation and smelting. The silver is finally extracted electrolytically by the
Moebius process, the Balbach-Thum process, or the Parkers process (Grayson
1983; Smith and Carson 1977).
World mine production in 1986 was 419.8 million troy ounces (for
conversion: troy ounces x 31.1034768 = grams) (Reese 1986). Mine production in
the United States declined from 1978 to 1986, reaching a low of 34.2 million
troy ounces in 1986, due to a combination of falling silver prices and rising
production costs (Reese 1986). This trend appeared to continue according to a
survey conducted by The Silver Institute in 1988 and 1989. The United States
production of silver from ores and concentrates was 3.4 and 4.2 million troy
ounces in 1988 and 1989, respectively. However, when recovered silver is
included in the production figures, total production was 8.8 and 9.3 million
troy ounces for 1988 and 1989, respectively (The Silver Institute 1990). United
States consumption in 1986 reached a high of 126.4 million troy ounces,-largely
due to increased industrial consumption and use in special issue coinage (Reese
1986). In 1987, the estimated consumption was 63.7 million troy ounces for the
United States and 172 million troy ounces worldwide (The Silver Institute 1988)
Since 1951, silver consumption has exceeded its extraction from ore.
Secondary silver production involves the recovery of silver from new and old
scrap, resulting from silver-containing wastes generated by industry and the
consumer. Recycled silver accounted for 40% of U.S. refinery production in 1971
and had increased to 67% by 1974 (Smith and Carson 1977). It was estimated to
be 61% and 56% in 1988 and 1989, respectively (The Silver Institute 1990). The
estimated world-wide recovery of silver from the photographic industry is about
67% of the total used (The Silver Institute 1988). It has been estimated that
80%, 68%, and 75% of today's annual consumption by the electrical, industrial-
alloy, and art industries, respectively, is recycled silver, but these
estimates may be high.
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4.2 IMPORT
The United States 1986 net import reliance approximated 60% of apparent
domestic consumption. Despite this, the 1986 U.S. dependence on foreign imports
decreased. Import levels fell from 152.6 million troy ounces in 1985 to 144.9
million troy ounces in 1986 (Reese 1986).
The largest decrease in imported silver was from the United Kingdom and
Switzerland. For these two countries import levels fell by 18.1 million ounces,
primarily in the form of refined bullion. A total of 125.4 million troy ounces
of refined silver were imported in 1986 with only 9.5 million troy ounces
accounted for in other forms.
U.S. exports of silver decreased slightly from 28.8 million troy ounces in
1985 to 25.1 million troy ounces in 1986 (Reese 1986).
4.3 USE
Silver metal and silver compounds have been and still are used in a wide
variety of ways. In the past, silver was used for surgical prostheses and/or
splints, fungicides (both of which are now obsolete), and coinage (discontinued
from general circulation within the United States in 1970).  Although silver
still serves some of the above functions, the current uses are even more
varied. Photographic materials accounted for 45% of the U.S. consumption in
1986. Electrical and electronic products, such as electrical contacts, silver
paints, and batteries, consumed approximately 25%. Silver has been an important
component in the manufacture of bearings in the past, although today its use in
this area is limited by cost and availability. Silver is also an important
component in brazing alloys and solders, which represent approximately 5% of
the 1986 silver consumption. More aesthetic uses of silver include
electroplated ware, sterling ware, and jewelry; in 1986, they accounted for 11%
of recorded uses.
Other uses account for the remaining 14%; these include use in mirrors,
dental amalgam, and medical supplies for treatment of burns, use as a catalyst
in the manufacture of formaldehyde and ethylene oxide, as an active agent for
purification and disinfection of drinking water and water in swimming pools, in
certain chemical analyses involving titration, and in cloud seeding
(Grayson 1983; HSDB 1988; NRC 1977; Smith and Carson 1977). Silver ions are
also used medically as an antibacterial agent (Becker 1987; Becker et al.1978;
Fox et al. 1969; Webster et al. 1981).
4.4 DISPOSAL
Treatment of air emissions containing silver is not a concern as
atmospheric emissions rarely approach the federal threshold limit value for
occupational exposure of 0.01 mg/m3 (Smith and Carson 1977).
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Moreover, as consumption of silver-containing products outweighs supply,
these products tend to be recycled whenever feasible. The largest source of
nonrecycled silver in the waste stream is attributable to photographic material
use by small-scale consumers (Smith and Carson 1977). This tends to be released
in the form of silver thiosulfate, which is converted into
insoluble silver forms by micro-organisms during wastewater treatment (Grayson
1983). Several methods have been suggested for recovering silver from various
waste media, including waste water, solid waste, and gas effluents. These
include electrolytic recovery, agglomeration, and metal concentration (CHMR
1989). At present the criteria for land disposal practices are undergoing
significant revision, and consultation with environmental regulatory agencies
is advised (HSDB 1988).
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5.1 OVERVIEW
Silver is a rare element, which occurs naturally in its pure form as a
white, ductile metal, and in ores. It has an average abundance of about 0.1 ppm
in the earth's crust and about 0.3 ppm in soils. There are four oxidation
states (0, l+, 2+, and 3+); the 0 and 1+ forms are much more common than the 2+
and 3+ forms. Silver occurs primarily as sulfides, in association with iron
(pyrite), lead (galena), and tellurides, and with gold. Silver is found in
surface waters in various forms: (1) as the monovalent ion (e.g., sulphide,
bicarbonate, or sulfate salts); (2) as part of more complex ions with chlorides
and sulfates; and (3) adsorbed onto particulate matter.
Silver is released to air and water through natural processes such as the
weathering of rocks and the erosion of soils. Important sources of atmospheric
silver from human activities include the processing of ores, steel refining,
cement manufacture, fossil fuel combustion, municipal waste incineration, and
cloud seeding. The total U.S. annual release of silver to
the environment as a result of human activities in 1978 was estimated to be
approximately 2 million kg. ,Of this amount, 77% was from,land disposal of
solid waste, 17% was discharged to surface waters, and 6% emitted to the
atmosphere. Ore smelting and fossil fuel combustion emit fine particles of
silver that may be transported long distances and deposited with precipitation.
The major source of release to surface waters is effluent from photographic
processing. Releases from the photographic industry and from disposal of sewage
sludge and refuse are the major sources of soil contamination with silver.
Sorption is the dominant process controlling partitioning in water and movement
in soil. Silver may leach from soil into groundwater; acidic conditions and
good drainage increase the leaching rate.  Silver is bioconcentrated to a
moderate extent in fish and invertebrates.
The general population is exposed to silver primarily through the
ingestion of drinking water and food. The most recent estimate by NIOSH
indicates that about 70,000 people are potentially exposed to silver in
workplace environments in the United States. Inhalation is probably the most
important route of occupational exposure. Populations with exposure to higher
than background levels of silver include workers in industries processing or
using the compound and members of the general public who consume drinking water
or food containing elevated levels of silver. Sources of elevated dietary
silver include seafood from areas near sewage outfalls or industrial sources
and crops grown in areas with high ambient levels of silver in the air
or soil.
According to the VIEW Database (1989), silver has been found at 27 sites
on the National Priority List of 1,177 sites. The frequency of these sites
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within the United States can be seen in Figure 5-l. EPA's Contract Laboratory
Program (CLP) statistical database indicates that silver has been detected at
100% of the 2,783 Superfund hazardous waste sites that have had samples of all
media analyzed by the CLP (CLP 1988).
5.2 RELEASES TO THE ENVIRONMENT
5.2.1 Air
The total U.S. annual anthropogenic release of silver to the atmosphere
from production processes and consumptive uses in 1978 was estimated at 77,700
kg (Scow et al. 1981). Of this amount, an estimated 30,000 kg were released
from metals production, 22,000 kg from use in electrical contacts and
conductors, 9,000 kg from coal and petroleum combustion, 7,000 kg from iron and
steel production, 2,000 kg from cement manufacture, and the remainder from
miscellaneous uses. Urban refuse was the source of an additional 10,000 kg.
Smith and Carson (1977) estimated that cloud seeding with silver iodide
contributed 3,100 kg annually (based on data from the early 1970s).
5.2.2 Water
The total U.S. annual release of silver to surface waters in 1978 from
production processes and consumptive uses was estimated to be 125,000 kg (Scow
et al. 1981). Of this amount, an estimated 65,000 kg were released from
photographic developing, 54,000 kg from photographic manufacture, 5,000 kg from
metals production, and the remainder from miscellaneous uses. An additional
70,000 kg were estimated to be released from sewage treatment plants, 72,000 kg
from urban runoff, and 438,000 kg from natural sources
(e.g., soil erosion). Silver released in precipitation as a result of cloud
seeding has decreased and is not expected to contribute significant amounts to
water (Scow et al. 1981). Leachates containing silver may enter ground waters
when tailing ponds or piles are situated in areas with high water tables or
when abandoned mines or sections of mines are saturated (Letkiewicz et al.
1984).
Other sources of silver release to surface waters include textile plant
wastewater effluent (Rawlings and Samfield 1979); petroleum refinery effluents
(Snider and Manning 1982); and quench water and fly ash scrubber water
effluents from municipal incinerators (Law and Gordon 1979). Silver was
detected in 7 of 58 (12%) samples from the National Urban Runoff Program
survey (Cole et al. 1984).
5.2.3 Soil
The total U.S. annual release of silver to land from production processes
and consumptive uses in 1978 was estimated at 1.01 million kg (Scow et al.
1981). Of this amount, an estimated 630,000 kg were released from the
photographic industry (in manufacture and developing), 165,000 kg from metals

72
5. POTENTIAL FOR HUMAN EXPOSURE
production, 150,000 kg from uses in electrical contacts and conductors, 60,000
kg from uses in brazing alloys and solders, and the remainder from
miscellaneous uses. An additional 370,000 to 520,000 kg were estimated to be
released from urban refuse and 220,000 kg from sewage treatment. Smith and
Carson (1977) estimated that the use of silver containing photographic
materials contributed an annual 370,000 kg in sewage sludge; of this amount an
estimated 52.5% was placed in landfills, 26.7% was lagooned, and 20.8% was
spread on land.
The major source of elevated silver levels in cultivated soils is from the
application of sewage sludge and sludge effluents as agricultural amendments.
Additional anthropogenic sources of silver in soil include atmospheric
deposition (especially from ore processing); landfilling of household refuse,
sewage sludge, or industrial wastes; and leaching of metal
tailings (Smith and Carson 1977).
5.3 ENVIRONMENTAL FATE
5.3.1 Transport and Partitioning
The global biogeochemical movements of silver are characterized by
releases to the atmosphere, water, and land by natural and man-made sources,
possible long-range transport of fine particles in the atmosphere, wet and dry
deposition, and sorption to soil and sediments. The major forms of silver in
the atmosphere are probably metallic silver, silver sulfide, silver sulfate,
silver carbonate, and silver halides (Smith and Carson 1977). Silver is
released to the atmosphere as an aerosol (suspension of solid or liquid
particles in a gas such as air). Mining operations such as grinding emit large
particles (more than 20 µ diameter) that settle near the source while
particles emitted from smelting, fossil-fuel fired power plants, and solid
waste incinerators are smaller and are likely to be transported away from the
source of release (Scow et al. 1981). Fine particles (less than 20 µ diameter)
in the aerosol tend to be transported long distances in the
atmosphere and are deposited with precipitation. Long-range atmospheric
transport of silver is indicated by several studies in which atmospheric
particulate concentrations were elevated above background levels in areas
removed from cloud seeding or mining activities (Davidson et al. 1985;
Struempler 1975). Scow et al. (1981) estimated that about 50% of the silver
released into the atmosphere from industrial operations will be transported
more than 100 km and will eventually be deposited by precipitation.
The transport and partitioning of silver in surface waters and soils is
influenced by the particular form of the compound. Lindsay and Sadiq (1979)
stated that under oxidizing conditions the primary silver compounds would be
bromides, chlorides, and iodides, while under reducing conditions the free
metal and silver sulfide would predominate. In water, the major forms of
silver are as the monovalent ion in the form of sulfate, bicarbonate, or
sulfate salts; as part of more complex ions with chlorides and sulfates; and
73
5. POTENTIAL FOR HUMAN EXPOSURE
as an integral part of, or adsorbed onto, particulate matter (Boyle 1968). In
one study, silver in river water was primarily found in the following forms:
silver ion (Ag+) -- 53-71%, silver chloride (Ag Cl°) -- 28-45%, silver chloride
ion (AgCl2-) -- 0.6-2.0% (Whitlow and Rice 1985). Callahan et al. (1979) stated
that sorption is the dominant process leading to the partitioning of silver in
sediments. Significant quantities of silver in water are sorbed by manganese
dioxide; pH and oxidation-reduction conditions affect sorption (Anderson et al.
1973). Kharkar et al. (1968) reported that approximately 90% of the silver in
rivers was in a dissolved form and 10% was a suspended solid. Concentrations in
lake sediments were reported to be 1000 times that of the overlying waters; the
highest content was associated with fine-grained sediments (Freeman 1977).
The mobility of silver in soils is affected by drainage (silver tends to
be removed from well-drained soils); oxidation-reduction potential and pH
conditions (which determine the reactivity of iron and manganese complexes
which tend to immobilize silver); and the presence of organic matter (which
complexes with silver and reduces its mobility) (Boyle 1968). The
distribution coefficient (Kd: ratio of the concentration in soil to the
concentration in water) for silver in a number of soils ranged from 10 to 1,000
(Baes and Sharp 1983). Factors that affect the Kd include soil pH, clay content
and particle size distribution, organic matter content, and free iron and
manganese oxide content. The enhanced ability of organic matter to immobilize
silver is demonstrated by the increased levels of silver found in peat and bog
soils and in marshes (Boyle 1968). In pasture plants growing in the vicinity of
an airborne source of silver such as a smelter, silver in the leaves is
apparently derived from deposition ,of airborne silver, while concentrations in
the roots are from soil uptake (Ward et al. 1979). Silver levels in the leaves
were slightly greater than levels in the roots.
Silver accumulation in marine algae appears to result from adsorption
rather than uptake; bioconcentration factors of 13,000-66,000 have been
reported (Fisher et al. 1984).
Data on the potential for accumulation of silver has been studied in
several aquatic species. Several of these studies do not conform to current
bioconcentration test procedures in terms of numbers of fish, duration of
exposure, and measurement of concentrations in aquaria. EPA (1980a) reported a
bioconcentration factor of less than 1 in bluegills (Lepomis macrochirus)
exposed to silver nitrate for 28 days. Approximate bioaccumulation factors of
4-6 for bluegill were calculated based on a 6-month study and 2-10 for large
mouth bass (Micropterus salmoides) exposed to silver nitrate for 4 months (both
dry weight) (Coleman and Cearley 1974).
Terhaar et al. (1977) studied bioconcentration (uptake from water) and
bioaccumulation (uptake from food and water) of silver thiosulfate complexes in
algae (Scenedesmus sp.), water flea (Daphnia magna), mussels (Ligumia sp. and
Margaritifera sp.), and fathead minnow (Pimephales promelas) in 10-week
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exposures. Bioconcentration indices were 96-150 for algae, 12.2-26 for Daphnia,
5.9-8.5 for mussels, and 1.8-28 for fish. Bioaccumulation indices were 9-26 for
Daphnia, 6.6-9.8 for mussels, and 4.0-6.2 for fish. These indices, which are
based on measured wet weight concentrations in biota and nominal concentrations
in water, indicate little potential for silver biomagnification (systematic
increase in residue concentrations moving up a food chain) in the tested
aquatic food chain.
Bioconcentration factors of 1,055-7,650 (wet weight) were estimated in a
21-month study with the mussel (Mytilus edulis) in salt water (Calabrese et al.
1984). The clam, Macoma balthica, contained silver at 32-133 µg/g (dry weight
tissue) in an area of San Francisco Bay near a sewage outfall; background
concentrations in this species in the bay were less than 1 µg/g (Thomson et al.
1984). These data indicate that inputs of silver to an estuary are available to
sediment-dwelling animals. Silver from sewage sludge at an ocean disposal site
was bioaccumulated by the sea scallop (Placopecten magellanicus). Maximum
concentrations in scallops located near the disposal site were 9.08 ppm (dry
weight tissue) while scallops located away from the site had levels less than 1
ppm (Pesch et al. 1977). The estimated biological half-lives for the
elimination of silver were 26.4 days for the Pacific oyster (Crassostrea gigas)
and 149.1 days for the American oyster (C. virginica) (Okazaki and Panietz
1981).
5.3.2 Transformation and Degradation
5.3.2.l Air
Particulates of metallic silver emitted from the burning of fossil fuels
and municipal refuse are likely to become coated with silver oxide, silver
sulfide, and silver carbonate as the particles cool and undergo deposition
(Smith and Carson 1977).
5.3.2.2 Water
In fresh water, silver may form complex ions with chlorides, ammonium (in
areas of maximum biological activity), and sulfates; form soluble organic
compounds such as the acetate and the tartrate; become adsorbed onto humic
complexes and suspended particulates; and become incorporated into, or adsorbed
onto, aquatic biota (Boyle 1968). Where decaying animal and plant
material are abundant, silver strongly precipitates as the sulfide or combines
with humic materials (Smith and Carson 1977).
5.3.2.3 Soil
Silver tends to form complexes with inorganic chemicals and humic
substances in soils (Boyle 1968). Since silver is toxic to soil microorganisms
and inhibits bacterial enzymes (Domsch 1984), biotransformation is not expected
to be a significant process.
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5.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT
5.4.1 Air
Silver was measured in particulate samples from rural and urban areas both
adjacent to and removed from activities such as metal smelting, refining, and
silver iodide cloud seeding. Background levels appear to be less than 1 ng/m3
as evidenced by the measurement of average silver concentrations of 0.018 ng/m3
at Great Smoky Mountains National Park; 0.012 ng/m3 at Olympic National Park;
and less than 0.19 ng/m3 at Glacier National Park (Davidson et
al. 1975). The highest particulate levels (mean -- 10.5 ng/m3; range -- 0.936-
36.5 ng/m3) were measured in Kellogg, Idaho (in the Coeur d'Alene River Basin)
near a large smelter complex (Ragaini et al. 1977). In an industrialized area
of northwest Indiana, silver was measured at less than l-5 ng/m3 (Harrison et
al. 1971). A level of 1 ng/m3 was reported by Douglas (1968) in a rural cloud-
seeding target area. In a rural area of Nebraska where no cloud seeding was
known to have occurred, Struempler (1975) found particulate silver
concentrations averaged 0.04-0.15 ng/m3 during three sampling periods. This
researcher theorized that anthropogenic sources, such as long-range transport
from cloud seeding, were responsible for the enrichment of silver by factors of
326-355 over its average concentration in the earth's crust. Silver
concentrations in precipitation resulting from seeding clouds with silver
iodide were 10-4500 ng/L compared with concentrations of 0-20 ng/L without
cloud seeding (Cooper and Jolly 1970).
5.4.2 Water
Boyle (1968) reported average (background) ambient concentrations of
silver in fresh waters of 0.2 µg/L and in sea water of 0.25 µg/L. Waters that
leach silver-bearing deposits (e.g., in mining areas) may carry up to 100 times
more silver than other fresh waters (Scow et al. 1981). Leaching is enhanced by
low pH (Smith and Carson 1977). In samples of 170 lakes in
California, silver concentrations averaged 0.1 µg/L with a maximum of 6.0 µg/L
(Bradford et al. 1968). Kharkar et al. (1968) reported that the average silver
concentration of 10 U.S. rivers was 0.30 µg/L (range: 0.092-0.55 µg/L).  In
another survey, Kopp (1969) found silver in 6.6% of 1,577 surface waters
sampled with a mean detected concentration of 2.6 µg/L (range: 0.1-38 µg/L).
For 1970-1979, according to U.S. surface water sampling data from EPA's STORET
database, the annual mean levels ranged from 1 µg/L to 9 µg/L and annual
maximum concentrations were 94 µg/L to 790 µg/L (Scow et al. 1981). In 10 out
of 13 major U.S. river basins, silver concentrations decreased from 1975-1979
as compared with 1970-1974. Concentrations increased in the North Atlantic,
Southeast, and Lower Mississippi basins. In the U.S. Geological Survey, Water
Resources Division portion of the database (from the early 1960s to mid-1988),
silver was detected in 2,195 of over 10,000 surface water samples; the mean
and median concentrations in these samples were 1.9 µg/L and 2.0 µg/L,
respectively (Eckel and Jacob 1988).
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Hem (1970) reported a median silver concentration of 0.23 µg/L in U.S.
drinking water. Letkiewicz et al. (1984) analyzed the results of three surveys
of U.S. groundwater and surface water used as drinking water supplies.  These
surveys were the 1969 U.S. Public Health Service Community Water Supply Survey
(CWSS 1969), the 1978 EPA Community Water Supply Survey (CWSS 1978), and the
1978 through 1980 EPA Rural Water Survey (RWS). In CWSS 1969, silver was
detected (minimum positive value was 0.1 µg/L) in 309 of 677 groundwater
supplies, (mean 1.7 µg/L, median 1.3 µg/L, and range 0.1 to 9 µg/L). Silver was
detected in 59 of 109 surface water supplies with a mean and median of 1.3 µg/L
and a range of 0.1 to 4 µg/L. In CWSS 1978, silver was detected (minimum
positive value was 30 µg/L) in 8 of 81 groundwater supplies (range 30-40 µg/L,
mean 31.9 µg/L, and median 30 µg/L). Silver was found in 4 of 25 surface water
supplies (range 30-40 µg/L, mean 36.2 µg/L, and median 37.5 µg/L). In the RWS
conducted between 1978 and 1980, silver was detected (minimum quantifiable
concentration apparently was 20 µg/L) in 10 of 71 groundwater supplies (mean
and median 40 µg/L and range 20-80 µg/L). Silver was detected in 8 of 21
surface water supplies. The range, mean, and median of these 8 supplies were
20-60 , µg/L, 36.2 µg/L, and 35 µg/L, respectively.  Letkiewicz et al. (1984)
also summarized information from EPA's Federal Reporting Data System as of
1984, which indicated that 14 public water supplies (13 from groundwater) in
the United States reported silver levels above 50 µg/L. Letkiewicz et al.
(1984) stated that it is not possible to determine which of these surveys is
representative of current levels of silver in the U.S. water supply. The large
range in apparent detection limits further limits the usefulness of these data
in estimating silver levels in U.S. water supplies.
Silver has been detected with a geometric mean concentration of 6.0 µg/L
in groundwater samples from 613 of the 2,783 (22%) hazardous waste sites
included in EPA's Contract Laboratory Program (CLP) statistical database (CLP
1988). It has also been detected in surface water samples from 552 of the 2,783
(20%) sites in the CLP statistical database with a geometric mean concentration
of 9.0 µg/L (CLP 1988).
5.4.3 Soil
From a series of measurements in Canada, Boyle (1968) estimated that the
average silver content of soils (except for mineralized zones such as mining
areas) was 0.30 ppm and the average abundance in the earth's crust was 0.10 ppm
. The major source of elevated silver levels in cultivated soils is from the
application of sewage sludge and sludge effluents (Smith and Carson 1977).  The
average silver concentration in soils near a lead smelting complex in Kellogg,
Idaho (in the Coeur d'hlene River Basin) was 20 ppm (range: 3.2-31 ppm)
(Ragaini et al. 1977). Klein (1972) measured soil metal concentrations in the
Grand Rapids, Michigan area in order to examine possible relationships between
concentrations and land use. Silver concentrations in soils that were
classified by land use were 0.13 ppm (residential), 0.19 ppm (agricultural),
and 0.37 ppm (industrial) (Klein 1972).
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The Contract Laboratory Program (CLP) statistical database indicates that
silver has been detected with a geometric mean concentration of 4.5 ppm in soil
samples from 1,807 of 2,783 (65%) hazardous waste sites that have had samples
analyzed by the CLP (CLP 1988).
5.4.4 Other Media
Coal has been reported to contain silver at concentrations of up to 10 ppm
(Boyle 1968). Klusek et al. (1983) measured the following silver concentrations
at a bituminous coal-fired electric generating station: coal -- 0.29 mg/kg; fly
ash -- 1.6 mg/kg; and bottom ash -- <0.l mg/kg. In the combustible portions of
municipal solid waste, mean silver concentrations were
3 ppm (range: <3-7 ppm) (Law and Gordon 1979). A municipal incinerator was
.found to emit particles containing 390 ppm silver (Law and Gordon 1979). The
mean and maximum silver concentrations i.n U.S sewage sludge were 225 mg/kg and
960 mg/kg (dry weight), respectively (Bunch 1982). Sludge silver concentrations
(mg/kg dry weight) were reported as follows: from sewage treatment plants with
industrial or municipal wastes -- 15-120 mg/kg; from plants with
photoprocessing effluents as a source -- 450-27,000 mg/kg (Lytle 1984) .
Scow et al. (1981) reported that the median silver concentrations in
sewage treatment plant influent and effluent were 0.008 mg/L and 0.002 mg/L,
respectively. Treated effluents from a large photographic processing plant
contained an average of 0.07 mg/L silver (range: <0.02-0.30 mg/L) in the form
of silver thiosulfntc: complexes, silver bromide, and silver sulfide (Bard et
al. 1976).
Cunningham and Stroube (1987) collected samples of various foods in 20
U.S. cities between 1979 and 1980. Silver concentrations (mg/kg wet weight) in
composite samples of the following food groups were: dairy products -- <0.061;
meat, fish, and poultry -- mean 0.015, range 0-87; cereal and grain products --
mean 0.008, range o-0.140; leafy vegetables .-- mean 0.007, range 0-0.039;
fruits -- <0.050; oils and fats -- <0.030. The average silver concentration of
a mixture of 201. foods prepared to represent the typical U.S. diet was 0.0091
mg/kg dry weight (Iyengar et al. 1987). The average concentration in cow's milk
in the United States has been reported to be 0.047 ppm (range:0.037-0.059 ppm)
(Murthy and Rhea 1968), EPA (1980a) summarized data on silver content in food
as follows: beef -- 0.004-0.024 mg/kg; pork
-- 0.007-0.012 mg/kg; mutton and lamb -- 0.006-0.011 mg/kg; tea -- 0.20-2.00
mg/kg (dry weight); mollusks -- 0.1-10.0 mg/kg.
Mean silver concentrations in one brand of nonfilter and filter cigarettes
were reported to be 0.18 mg/kg and 0.27 mg/kg, respectively (Nadkarni et al.
1970).
In a summary of 1975-1979 data on fish tissue from EPA's STORET database,
the mean concentration of silver in 221 samples was 0.225 mg/kg (wet weight
78 
5. POTENTIAL FOR HUMAN EXPOSURE 
total fish), with a range of 0.004-1.900 mg/kg (Scow et al. 1981). In Lake 
Pontchartrain, Louisiana (which is likely to receive substantial inputs of 
metals from municipal and agricultural activities) silver concentrations in 
clams and American oyster tissues were 0.4-2.4 mg/kg and 5.5 mg/kg (all dry 
weight), respectively (Byrne and DeLeon 1986)  
5.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE 
Food and water are the most likely major sources of exposure to natural 
and anthropogenic silver for the general U.S. population (Letkiewicz et al. 
1984). 
airborne silver and the dental and medical uses of silver. Letkiewicz et al. 
(1984) estimated that about 50% of the 214 million people in the United States 
who use public drinking water supplies had silver present in their water at 
0.01-10 pg/L; 10-30% may receive water with levels greater than 30 pg/L. They 
estimated that 46,000 people in the U.S. receive drinking water with silver 
concentrations exceeding the current U.S. Safe Drinking Water Act maximum 
contaminant limit of 50 pg/L. 
containing systems is another possible source of exposure to silver. 
The general population is also exposed through the inhalation of 
Swimming pool water purified with silver- 
The averaged daily dietary intake (including fluids) of silver has been 
estimated to be 70 pg/day (Snyder et al. 1975) and 88 pg/day (Kehoe et al. 
1940). The average daily dietary intake of two subjects over 30 days was 
determined to be 35-44 pg/day (Tipton et al. 1966). The silver content of 
food was estimated at 4.5 pg/day based on the content of a mixture of 201 
foods prepared to represent the typical U.S. diet (Iyengar et al. 1987). Most 
of the U.S. population breathes air containing a maximum o f  1.0 ng/m3 silver, 
which contributes a maximum of 0.023 pg/day. Drinking water supplies 
containing 10 pg/L would provide an estimated 20 pg/day of the 70-88 pg/day 
estimated daily intake. 
60-100 ,ug/day (based on an estimated daily water intake of 2 L) and 
constitutes the major source of silver intake (Letkiewicz et al. 1984). 
Although silver has been detected in cigarettes, the average daily intake from 
smoking has not been determined. A very limited use of silver salts is in 
purification systems in isolated locations (such as mountain cabins and in 
space missions) (Silver Institute 1975). 
At levels of 30-50 pg/L, drinking water contributes 
The 1972-1974 National Occupational Hazard Survey (NOHS), conducted by 
NIOSH estimated that 19,343 workers in 2,163 plants were potentially exposed 
to silver in 1970 (NIOSH 1976). The largest number of exposed workers were in 
special trade contracting, primary metal industries, and industries using 
electrical machinery and electrical equipment and supplies. 
groups with the largest number o f  exposed workers were air conditioning, 
heating and refrigeration mechanics and repairmen; plumbers and pipefitters; 
miscellaneous assemblers; welders and flamecutters; and miscellaneous machine 
operators. 
The occupational 
79
5. POTENTIAL FOR HUMAN EXPOSURE
Preliminary data from a second workplace survey, the 1980-1983 National
Occupational Exposure Survey (NOES) conducted by NIOSH, indicated that 67,054
workers, including 15,763 women, in 3,123 plants were potentially exposed to
silver in the workplace in 1980 (NIOSH 1984a). These estimates were derived
from observations of the actual use of silver (67% of total estimate) and the
use of trade name products known to contain the compound (33%). The largest
number of workers were exposed in the primary metal industries, business
services, health services, instruments and related products industries, and
fabricated metal products industries.
Neither the NOHS nor the NOES databases contain information on the
frequency, concentration, or duration of exposure of workers to any of the
chemicals listed therein. These surveys provide only estimates of the number of
workers potentially exposed to chemicals in the workplace.
Additional industrial processes which act as potential sources of
occupational exposure to silver include the processing of silver chemicals such
as silver nitrate and silver oxide for uses such as photography, and smelting
and refining of silver-containing ores (DiVincenzo et al. 1985).
5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES
The most likely sources of higher than background levels of silver for the
general population are ingestion of contaminated food and drinking water, The
estimated 46,000 persons in the United States whose drinking water contains
more than 50 µg/L silver (attributable to natural and/or anthropogenic sources)
would have an estimated daily intake of at least 100 µg/day from water alone
(Letkiewicz et al. 1984). Higher levels of silver have been detected in
shellfish near industrial or sewage inputs (Byrne and DeLeon 1986; Pesch et al.
1977; Thomson et al. 1984) and are likely to occur in crops grown on sludge-
amended soils, in the vicinity of smelters or mining operations, or in areas
with naturally high background silver levels.
Elevated atmospheric silver concentrations have been attributed to
smelting and refining of silver and other metals, and the use of silver iodide
in cloud seeding (Scow et al. 1981). Populations living close to mines may have
higher exposures. Approximately 71% of domestic mine production occurs in
Idaho, Arizona, and Colorado; the Coeur d'Alene River Basin in Idaho
supplies the greatest amount of silver (Drake 1980). Crops grown on soils with
elevated silver concentrations (either from anthropogenic sources or from
naturally high background levels) or exposed to high ambient atmospheric
concentrations are likely to become enriched with silver (Ragaini et al. 1977;
Ward et al, 1979).
Silver has been used in lozenges and chewing gums designed to aid the
cessation of smoking. Silver acetate in chewing gum has been classified as an
over-the-counter smoking deterrent by the Food and Drug Administration (Malcolm
et al. 1986). Several cases of high body levels of silver have been
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reported (Malcolm et al. 1986). A skin silver concentration thousands of times
higher than would be expected as a normal value was found in a patient after an
estimated 6 month exposure to silver acetate lozenges (East et al. 1980;
MacIntyre et al. 1978).
Scow et al. (1981) estimated that a person developing six rolls of film
could be exposed to up to 16 grams of silver through dermal contact with
photographic solutions. However, many people use implements or wear gloves
during film developing and therefore this is not expected to result in
widespread, high level exposures. Inhalation was not expected to be a
significant route of uptake during film processing because of the low
volatility of silver in solution.
5.7 ADEQUACY OF THE DATABASE
Section 104 (i) (5) of CERCLA, directs the Administrator of ATSDR (in
consultation with the Administrator of EPA and agencies and programs of the
Public Health Service) to assess whether adequate information on the health
effects of silver is available. Where adequate information is not available,
ATSDR, in conjunction with the National Toxicology Program (NTP), is required
to assure the initiation of a program-of research designed to determine the
health effects (and techniques for developing methods to determine such health
effects) of silver.
The following categories of possible data needs have been identified by a
joint team of scientists from ATSDR, NTP, and EPA. They are defined as
substance-specific informational needs that, if met would reduce or eliminate
the uncertainties of human health assessment. In the future, the identified
data needs will be evaluated and prioritized, and a substance-specific research
agenda will be proposed.
5.7.1 Identification of Data Needs
Physical and Chemical Properties.  No data exist on the partition
coefficients and Henry's law constant for silver and its compounds. A vapor
pressure has been determined for silver at very high temperatures (greater than
900°C), but not for any of its compounds. Generally, the fate of silver in the
environment is fairly well understood; however, a determination of these
environmentally relevant values for silver compounds might provide a
more complete estimation of the fate of silver in the environment. Tables 3-7
to 3-12 contain information on the known physical and chemical properties of
silver and several important silver compounds.
Production, Use, Release, and Disposal.  The production, use, release, and
disposal of silver is well characterized and indicates that risk of exposure
for the general population is potentially high. Silver and silver compounds are
produced and used for a wide variety of common products and
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applications, including photographic materials, jewelry, tooth amalgams,
medical supplies, and water purification. The extensive production and use of
silver leads to a high risk of release to the environment, particularly to soil
and water. Silver has been detected in various food products, with the highest
levels detected in fish. Silver is both rare and valuable, and consumption
exceeds production. Therefore, manufacturers attempt to conserve the metal by
limiting releases and recycling instead of disposing of the metal. Methods
exist for recovering silver from several waste media. Improvements in capturing
released silver before it reaches the environment would be beneficial for both
economic and health reasons.
According to the Emergency Planning and Community Right-to-Know Act of
1986, 42 U.S.C. Section 11023, industries are required to submit chemical
release and off-site transfer information to EPA. The Toxics Release Inventory
(TRI), which contains this information for 1987, became available in May of
1989. This database will be updated yearly and should provide a list of
industrial production facilities and emissions.
Environmental Fate.  The factors governing the environmental fate of
silver are not well characterized. While silver and its compounds are
transported in the air, water, and soil, and are partitioned between these
media, the mechanisms of transport and partitioning are not well-defined. No
partition coefficients or constants have been determined for silver or its
compounds. Little information was found in the available literature on
transformation of silver in water or soil. Some microorganisms present in these
media may be able to transform si1ver and silver compounds; however, silver is
not expected to be significantly transformed in the environment
because it is toxic to microorganisms. Further information on the size and flux
of environmental compartments and the transport and transformations of silver
and silver compounds in the environment would be useful in defining pathways
for potential human exposure.
Bioavailability from Environmental Media.  Silver is known to be absorbed
from the lungs following inhalation exposure to silver dust or air contaminated
with silver compounds, but data on the extent and rate of absorption are
limited. Silver is also absorbed following oral or dermal exposure to drinking
water, solutions and medical products containing silver compounds. No data were
located on bioavailability of silver from soil, plant material, or foods.
However, silver is found in all these environmental media and it is likely that
some silver might be absorbed from these sources.  Further information on the
bioavailability of silver from contaminated air, water, soil, plants, and other
foods would help in assessing the health risk
associated with increased exposures that might occur in populations in the
vicinity of hazardous waste sites.
Food Chain Bioaccumulation.  The data available indicate that silver can
bioconcentrate to a limited extent in algae, mussels, clams, and other aquatic
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Food Chain Bioaccumulation.  The data available indicate that silver can
bioconcentrate to a limited extent in algae, mussels, clams, and other aquatic
organisms. However, many of the studies that were performed do not conform to
the current state of the art in terms of sample size, duration, and analysis of
contaminant levels in aquaria. Reliable data would be useful in determining the
possibility of biomagnification and in defining pathways for
general population exposure, as well as in estimating exposures from NPL site
contamination.
Exposure Levels in Environmental Media.  Silver has been detected in all
environmental media, but most of the data are not current. Current data from
EPA's CLP indicate silver is found at levels above background in ground water,
surface water and soil near hazardous waste sites. Elevated levels of silver
have been detected in shellfish located near sources of silver pollution.
Estimates of average daily human intake from air, drinking water, food, and
total diet have been calculated. More current information, that better defines
major sources and forms of silver, would increase the accuracy of estimates of
daily exposure to silver. This information could be used to develop a more
thorough representation of the contribution of silver exposure from
contamination at hazardous waste sites. Data that better characterize levels in
fish and shellfish would aid in identifying populations with potentially high
exposures to silver from these sources.
Exposure Levels in Humans.  Silver has been detected in the blood,
tissues, urine, and feces of humans. The only biological monitoring studies
located consisted of small numbers of worker populations in chemical
manufacturing industries. Studies that better characterize important sources of
general population exposure and define populations with potentially high
exposure, such as those located near hazardous waste sites, would be helpful.
More specific information concerning the chemical form of silver present at
hazardous waste sites would also be useful. These data would assist in
developing a more accurate estimate of the potential for silver exposure from
hazardous waste sites contaminated with the metal.
Exposure Registries.  No exposure registries for silver were located.
This compound is not currently one of the compounds for which a subregistry has
been established in the National Exposure Registry. The compound will be
considered in the future when chemical selection is made for subregistries to
be established. The information that is amassed in the National Exposure
Registry facilitates the epidemiological research needed to assess adverse
health outcomes that may be related to the exposure to this compound.
5.7.2 On-going Studies
No long-term research studies on the environmental fate of silver were
identified. However, environmental monitoring being conducted in conjunction
with remedial investigation/feasibility studies at NPL sites where silver has
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been found should add useful information regarding environmental
concentrations, chemical species, fate, and transport of the compounds.
No on-going studies or long-term research concerning occupational or
general population exposures to silver were identified.
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6. ANALYTICAL METHODS
The purpose of this chapter is to describe the analytical methods that are
available for detecting and/or measuring and monitoring silver in environmental
media and in biological samples. The intent is not to provide an exhaustive
list of analytical methods that could be used to detect and quantify silver.
Rather, the intention is to identify well-established methods that are used as
the standard methods of analysis. Many of the analytical methods used to detect
silver in environmental samples are the methods approved by federal agencies
such as EPA and the National Institute for Occupational Safety and Health
(NIOSH). Other methods presented in this
chapter are those that are approved by a trade association such as the
Association of Official Analytical Chemists (AOAC) and the American Public
Health Association (APHA). Additionally, analytical methods are included that
refine previously used methods to obtain lower detection limits, and/or to
improve accuracy and precision.
The analytical methods used to quantify silver in biological and
environmental samples are summarized in two tables. Applicable analytical
methods for determining silver in biological fluids and tissues are listed in
Table 6-1, and those used'for determining silver in various environmental
samples are listed in Table 6-2.
6.1 BIOLOGICAL MATERIALS
Trace levels (10-6 to 10-9 g/g of sample) of silver can be accurately
determined in biological samples by several different analytical techniques,
provided that the analyst is well acquainted with the specific problems
associated with the chosen method. These methods include high frequency plasma
torch-atomic emission spectroscopy (HFP-AES), neutron activation
analysis (NAA)., graphite furnace (flameless) atomic absorption spectroscopy
(GFAAS), flame atomic absorption spectroscopy (FAAS), and micro-cup atomic
absorption spectroscopy (MCAAS).
Atomic absorption spectroscopy equipped with various atomizers is the best
and most prevalent analytical method used to analyze trace amounts of silver in
biological tissues and fluids. GFAAS offers high detectability
(subnanogram/gram of sample) and requires relatively small samples for analysis
of biological tissues (DiVincenzo et al. 1985; Segar and Gilio 1973).
Background absorption from sample matrix components can be a problem, but
correction using a deuterium continuum light source is adequate if cautiously
applied (Segar and Gilio 1973). The detection limit of silver in biological
tissues was 2x10-5 µg/g of sample.
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Recently, Starkey et al. (1987) modified the GFAAS technique for
determining trace levels of silver in the blood of exposed and unexposed
individuals. Ethylene diamine tetraacetic acid (anticoagulant) and ammonium
hydrogen phosphate buffer (matrix modifier) were added to blood samples prior
to analysis. Starkey and co-workers indicated that the GFAAS technique is
highly selective and sensitive and does not require a complex sample
pretreatment (ashing and digestion with strong acids). A detection limit of
15x10-3 µg/l00 mL of sample was reported.
Howlett and Taylor (1978) used an atomic absorption spectroscopy fitted
with a micro-cup assembly (MCAAS) for determining silver levels in human whole
blood. The MCAAS technique affords a rapid, precise, and relatively simple
method for the measurement of silver in blood. Furthermore, this technique
requires no sample preparation prior to analysis except pipetting and drying.
A detection limit level of 0.27 µg/l00 mL of blood sample was measured.
Howlett and Taylor (1978) noted that repeated measurement of silver in blood
using a single nickel cup showed a gradual decrease in sensitivity.
FAAS technique has been successfully used to detect levels of silver in
post-mortem human liver; the detection limit for this method was 0.34 µg/g
(Johnson 1976).
HFP-AES can determine ng amounts of silver in a small sample of human
blood. Prepared human blood sample was introduced into the atomizer chamber as
an aerosol, formed by nebulization of the sample solution (Nakashima et al.
1975). The authors noted that the sensitivity of the HFP-AES technique was
improved by eliminating moisture in the aerosol with a second condenser at -3
to -5°C. The use of bismuth as a coprecipitate showed an enhancing effect on
the silver emission at 328.06 nm. A detection limit of 0.25 µg/l00 mL of sample
was attainable. Advantages of the HFP-AES methodology include freedom from most
types of chemical interference, high sensitivity, and multielemental
capability. However, this technology might have to be adapted to currently
available instrumentation in order to be useful. The presence of
spectral interferences is a disadvantage of plasma emission spectroscopy.
These interferences are caused when a sample contains elements that have
analytical emission lines that overlap the line chosen for the analyte. Blood
is particularly troublesome because of high concentration of iron. Iron has a
very complex emission spectrum. Also, the analytical line for silver used in
the Nakashima et al. paper has interference from manganese. For this reason,
the blood is subjected to dangerous perchloric acid/nitric acid digestion and
preconcentration of silver ion prior to analysis. Other inherent disadvantages
of HFP-AES include the employment of time-consuming procedure, the need for
standard additions for accurate quantification, and its high costs when
compared to GFAAS. Unless a laboratory is already furnished with the
instrumentation, purchase of HFP-AES is not recommended for the analysis of
silver alone. GFAAS or even DCP-AES could be employed for the determination of
silver in biological samples.
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Owing to its high sensitivity, the NAA technique has been widely employed
for determination of trace elements (including silver) in biological and
environmental samples. The NAA technique is based on interaction of the nuclei
of individual silver atoms of the sample with neutron irradiation, resulting in
the emission of γ-rays (photons). The radioactivity of the irradiated sample is
measured with a high-resolution lithium-drifted germanium detector. The long-
lived, metastable 110mAg isotope of silver was formed following irradiation of
human hair samples. A half-life of 250.4 days for 110mAg gives ample time to
initiate counting after an irradiation and cooling period (Dutkiewicz et al.
1978). The authors noted a detection limit for silver of 0.69 ppm in human
hair. (See Section 2.5 for a discussion of the disadvantages of using hair
samples for monitoring exposure to silver.) A disadvantage of NAA is that it is
a very expensive technique and may not be readily available in most
laboratories.
DiVincenzo et al. (1985) employed the GFAAS technique to evaluate human
samples for biological monitoring of silver exposure levels in the workplace.
The authors determined the total silver concentration in urine, blood, feces,
and hair with detection limits of 0.005 µg/L,0.5 µg/100 mL, 0.2 µg/g, and 0.02
µg/g, respectively.
Scanning electron microscopy (SEM) in concert with x-ray energy
spectrometry (XES) has been used to detect silver in pulmonary, lacrimal sac,
and skin tissues of individuals with diffuse interstitial lung disease, chronic
dacryocystitis, and skin disorders, respectively (Brody et al. 1978; Loeffler
and Lee 1987; Tanita et al. 1985). Brody et al. (1978) observed particles of
preselected lesions of human pulmonary tissue magnified to 300x by SEM, and the
silver content was analyzed by XES. The authors noted that SEM and XES
techniques permit a rapid and conclusive determination of silver, silver
compounds, and complexes in tissue lesions.
6.2 ENVIRONMENTAL SAMPLES
Atomic absorption and plasma emission spectroscopy are perhaps the most
widely used analytical techniques for the determination of silver levels in
air, soil, and water.  Rains et al. (1984) employed atomic absorption
spectroscopy with flame atomization (FAAS) and direct current plasma-atomic
emission spectroscopy (DCP-AES) to determine silver levels in solid-waste
leachate. In the FAAS technique, a diluted solution of the sample following
ashing and digestion is sprayed into a flame by means of a nebulizer. The high
temperature causes formation of atoms, which can be observed (at 328.1 nm
resonance line) by absorption spectroscopy. The authors noted that interference
encountered by the FAAS technique was largely alleviated by the use of 1%
solution of ammonium dibasic phosphate buffer as a matrix modifier. In the DCP-
AES technique, Rains and co-workers observed silver as a broad band emission at
328.068 nm resonance line. Addition of lithium carbonate to sample solution
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reduces the inter-element interferences observed in unbuffered direct-current
plasmas, but does not significantly degrade DCP-AES detection limits.
Detection limits of silver in solid-waste leachate sample by FAAS and DCP-AES
techniques were 0.473x10-6 g/mL sample and 0.38x10-6 g/L sample, respectively
(Rains et al. 1984).
GFAAS technique is more sensitive than FAAS methodology for determination
of silver in water samples. Rain and stream water have been analyzed by GFAAS
technique to detect silver at ng/mL levels (Rattonetti 1974).
Inductively coupled argon plasma with atomic emission spectroscopy
(ICP-AES) has been recommended by NIOSH (method 7300) for determining silver
in air. ICP-AES offers multi-element capabilities and high sensitivity but
spectral (background) interference can be a problem (NIOSH 1984b). The
EPAestablished analytical test procedure (method 200.7) to analyze dissolved,
suspended or total silver in drinking water, surface water, and domestic and
industrial wastewaters employs the ICP-AES technique (EPA 1987a). An
estimated detection limit of 7.0x10-6 g silver/L sample was measured.
Neutron activation analysis (NAA) methodology has been used to determine
silver levels in environmental samples. Bogen (1973) reported a detection limit
of 8x10-9 g silver/l0 cm2 filter. The author indicated that the use of high-
resolution lithium-drifted-germanium detection allows multi-elemental analysis
to be performed in a single measurement without any chemical pretreatment of
the air sample. A highly precise, sensitive, and
nondestructive computer-assisted NAA technique for the determination in air of
multi-element particulate matter has been designed by Dams et al. (1970). The
authors reported a detection limit of 1x10-7 g silver/sample. The NAA technique
by Bogen (1973) and Dams et al. (1970), utilizes the long-lived isotope of
silver (110mAg ) for quantifying silver levels in air. The faster
nondestructive NAA technique developed by Dams et al. (1970) utilizes the
short-lived isotope 110Ag (half-life = 24.6 seconds) to detect silver in air
following an 18-second neutron irradiation of air sample. Hence, counting can
be initiated after an irradiation and cooling period of a few minutes.
Hung et al. (1982) developed a sensitive and selective method for silver
analysis by reacting silver (I) with 2(-3,5-dibromo-2-pyridylazo)-5-diethyl
amino phenol in the presence of an anionic surfactant, sodium lauryl sulfate.
The ternary complex formed is red and exhibits an absorption peak at 570 nm.
Hung and his co-workers employed EDTA as a chelating agent, thereby reducing
the interference of common ions. Recoveries were good, and a detection limit of
0.39 ppm of silver was achieved.
Paper chromatographic, micro thin-layer chromatographic (TLC) and
photodensitometric (PD) methods have also been successfully used to determine
levels of silver compounds in freshwater and eye lotion samples (Devi and Kumar
1981; Massa 1969). Simple paper and micro thin layer chromatographic (TLC)
techniques were employed by Devi and Kumar (1981) to detect and quantify
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trace (40 ppm) levels of silver nitrate in fresh water. Devi and Kumar reacted
a prepared silver nitrate sample with succinate dehydrogenase enzymechromogenic
reagent complex solution prior to paper chromatographic or micro TLC analysis.
The metals are recognized by their ability to inhibit the enzymatic formation
of a pink reaction product.
Soil samples have been analyzed for silver by AAS (Klein 1972), NAA, and
x-ray fluorescence analysis (Ragaini et al. 1977). No statements on the
sensitivity, accuracy, or precision of these methods for soil analysis were
presented in the brief description of these methods.
6.3 ADEQUACY OF THE DATABASE
Section 104 (i) (5) of CERCLA, directs the Administrator of ATSDR (in
consultation with the Administrator of EPA and agencies and programs of the
Public Health Service) to assess whether adequate information on the health
effects of silver is available. Where adequate information is not available,
ATSDR, in conjunction with the National Toxicology Program (NTP), is required
to assure the initiation of a program of research designed to determine the
health effects (and techniques for developing methods to determine such health
effects) of silver.
The following categories of possible data needs have been identified by a
joint team of scientists from ATSDR, NTP, and EPA. They are defined as
substance-specific informational needs that, if met would reduce or eliminate
the uncertainties of human health assessment. In the future, the identified
data needs will be evaluated and prioritized, and a substance-specific
research agenda will be proposed.
6.3.1 Identification of Data Needs
Methods for Determining Biomarkers of Exposure and Effect.  Existing
methods of measuring levels of silver in blood, urine, feces, hair, and tissues
are extremely sensitive and can measure levels in the low ppm to ppt.  These
methods are accurate and reliable and can be used to measure both background
levels of exposure and levels at which biological effects occur.  No additional
analytical methods for determining trace levels of silver in
biological materials are needed.
Highly sensitive methods exist to measure silver concentrations in blood,
urine, hair, and skin samples of individuals showing the few health effects
that have been associated with silver exposure. These methods are also able to
accurately measure background levels in the population. No additional
analytical methods appear to be needed for the known biomarkers of effect.
Methods for Determining Parent Compounds and Degradation Products in
Environmental Media.  Sophisticated and highly refined methods are available
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to detect trace levels of silver and its compounds in air, solid waste
leachate, water (the medium of most concern for human exposure), food, and
other environmental media. These methods can accurately measure background
levels in environmental samples, as well as levels at which health effects
occur. There are no known deficiencies in the analytical methods for
determining silver in environmental media, and no additional analytical methods
appear to be necessary.
6.3.2 On-Going Studies
No on-going studies concerning techniques for measuring and determining
silver in biological and environmental samples were located.
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7. REGULATIONS AND ADVISORIES
Silver is on the list of chemicals appearing in "Toxic Chemicals Subject
to Section 313 of the Emergency Planning and Community Right-to-Know Act of
1986" (EPA 1987b).
No international regulations pertaining to silver were found. The national and
state regulations and guidelines regarding silver in air, water, and other
media are summarized in Table 7-1.
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Acute Exposure -- Exposure to a chemical for a duration of
specified in the toxicological profiles.
Adsorption Coefficient (Koc) -- The ratio of the amount of a chemical adsorbed
per unit weight of organic carbon in the soil or sediment to the concentration
of the chemical in solution at equilibrium.
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment or
soil (i.e., the solid phase) divided by the amount of chemical in the solution
phase, which is in equilibrium with the solid phase, at a fixed solid/solution
ratio. It is generally expressed in micrograms of chemical sorbed per gram of
soil or sediment.
Bioconcentration Factor (BCF) -- The quotient of the condentration of a
chemical in aquatic organisms at a specific time or during a discrete time
period of exposure divided by the concentration in the surrounding water at
the same time or during the same period.
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study, or group
of studies, that produces significant increases in the incidence of cancer (or
tumors) between the exposed population and its appropriate control.
Carcinogen -- A chemical capable of inducing cancer.
Ceiling Value -- A concentration of a substance that should not be exceeded,
even instantaneously.
Chronic Exposure -- Exposure to a chemical for 365 days or more, as specified
in the Toxicological Profiles.
Developmental Toxicity -- The occurrence of adverse effects on the developing
organism that may result from exposure to a chemical prior to conception
(either parent), during prenatal development, or postnatally to the time of
sexual maturation. Adverse developmental effects may be detected at any point
in the life span of the organism.
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as a
result of prenatal exposure to a chemical; the distinguishing feature between
the two terms is the stage of development during which the insult occurred.
The terms, as used here, include malformations and variations, altered growth,
and in utero death.
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EPA Health Advisory -- An estimate of acceptable drinking water levels for a
chemical substance based on health effects information. A health advisory is
not a legally enforceable federal standard, but serves as technical guidance
to assist federal, state, and local officials.
Immediately Dangerous to Life or Health (IDLH) -- The maximum environmental
concentration of a contaminant from which one could escape within 30 min
without any escape-impairing symptoms or irreversible health effects.
Intermediate Exposure -- Exposure to a chemical for a duration of 15-364 days
as specified in the Toxicological Profiles.
Immunologic Toxicity -- The occurrence of adverse effects on the immune system
that may result from exposure to environmental agents such as chemicals.
In Vitro -- Isolated from the living organism and artificially maintained, as
in a test tube.
In Vivo -- Occurring within the living organism.
Lethal Concentration(LO) (LCLO) -- The lowest concentration of a chemical in
air which has been reported to have caused death in humans or animals.
Lethal Concentration(50) (LC50) -- A calculated concentration of a chemical in
air to which exposure for a specific length of time is expected to cause death
in 50% of a defined experimental animal population.
Lethal Dose(LO) ( LDLO) -- The lowest dose of a chemical introduced by a route
other than inhalation that is expected to have caused death in humans or
animals.
Lethal Dose(50) (LD50) -- The dose of a chemical which has been calculated to
cause death in 50% of a defined experimental animal population.
Lethal Time(50) (LT50) -- A calculated period of time within which a specific
concentration of a chemical is expected to cause death in 50% of a defined
experimental animal population.
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of chemical in
a study, or group of studies, that produces statistically or biologically
significant increases in frequency or severity of adverse effects between the
exposed population and its appropriate control.
Malformations -- Permanent structural changes that may adversely affect
survival, development, or function.
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Minimal Risk Level -- An estimate of daily human exposure to a chemical that
is likely to be without an appreciable risk of deleterious effects
(noncancerous) over a specified duration of exposure.
Mutagen -- A substance that causes mutations. A mutation is a change in the
genetic material in a body cell. Mutations can lead to birth defects,
miscarriages, or cancer.
Neurotoxicity -- The occurrence of adverse effects on the nervous system
following exposure to chemical.
No-Observed-Adverse-Effect Level (NOAEL) -- The dose of chemical at which
there were no statistically or biologically significant increases in frequency
or severity of adverse effects seen between the exposed population and its
appropriate control. Effects may be produced at this dose, but they are not
considered to be adverse.
Octanol-Water Partition Coefficient (Kow) -- The equilibrium ratio of the
concentrations of a chemical in n-octanol and water, in dilute solution.
Permissible Exposure Limit (PEL) -- An allowable exposure level in workplace
air averaged over an 8-hour shift.
q1* -- The upper-bound estimate of the low-dose slope of the dose-response
curve as determined by the multistage procedure. The q1* can be used to
calculate an estimate of carcinogenic potency, the incremental excess cancer
risk per unit of exposure (usually µg/L for water, mg/kg/day for food, and
µg/m3 for air).
Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps an
order of magnitude) of the daily exposure of the human population to a
potential hazard that is likely to be without risk of deleterious effects
during a lifetime. The RfD is operationally derived from the NOAEL (from
animal and human studies) by a consistent application of uncertainty factors
that reflect various types of data used to estimate RfDs and an additional
modifying factor, which is based on a professional judgment of the entire
database on the chemical. The RfDs are not applicable to nonthreshold effects
such as cancer.
Reportable Quantity (RQ) -- The quantity of a hazardous substance that is
considered reportable under CERCLA. Reportable quantities are (1) 1 lb or
greater or (2) for selected substances, an amount established by regulation
either under CERCLA or under Sect. 311 of the Clean Water Act. Quantities are
measured over a 24-hour period.
144
9. GLOSSARY
Reproductive Toxicity -- The occurrence of adverse effects on the reproductive
system that may result from exposure to a chemical. The toxicity may be
directed to the reproductive organs and/or the related endocrine system. The
manifestation of such toxicity may be noted as alterations in sexual behavior,
fertility, pregnancy outcomes, or modifications in other functions that are
dependent on the integrity of this system.
Short-Term Exposure Limit (STEL) -- The maximum concentration to which workers
can be exposed for up to 15 min continually. No more than four excursions are
allowed per day, and there must be at least 60 min between exposure periods.
The daily TLV-TWA may not be exceeded.
Target Organ Toxicity -- This term covers a broad range of adverse effects on
target organs or physiological systems (e.g., renal, cardiovascular) extending
from those arising through a single limited exposure to those assumed over a
lifetime of exposure to a chemical.
Teratogen -- A chemical that causes structural defects that affect the
development of an organism.
Threshold Limit Value (TLV) -- A concentration of a substance to which most
workers can be exposed without adverse effect. The TLV may be expressed as a
TWA, as a STEL, or as a CL.
Time-Weighted Average (TWA) -- An allowable exposure concentration averaged
over a normal 8-hour workday or 40-hour workweek.
Toxic Dose (TD50) -- A calculated dose of a chemical, introduced by a route
other than inhalation, which is expected to cause a specific toxic effect in
50% of a defined experimental animal population.
Uncertainty Factor (UF) -- A factor used in operationally deriving the RfD
from experimental data. UFs are intended to account for (1) the variation in
sensitivity among the members of the human population, (2) the uncertainty in
extrapolating animal data to the case of human, (3) the uncertainty in
extrapolating from data obtained in a study that is of less than lifetime
exposure, and (4) the uncertainty in using LOAEL data rather than NOAEL data.
Usually each of these factors is set equal to 10.
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APPENDIX
PEER REVIEW
A peer review panel was assembled for silver. The panel consisted of the
following members: Dr. Rajendar Abraham, Abraham Associates Limited, Albany,
NY; Dr. Thomas Hinesly, University of Illinois, IL; Dr. Arthur Furst,
University of San Francisco, CA; Dr. Ernest Foulkes, University of Cincinnati,
OH. These experts collectively have knowledge of silver's physical and chemical
properties, toxicokinetics, key health end points, mechanisms of action, human
and animal exposure, and quantification of risk to humans. All reviewers were
selected in conformity with the conditions for peer review specified in Section
104 (i) (13) of the Comprehensive Environmental Response, Compensation, and
Liability Act, as amended.
A joint panel of scientists from ATSDR and EPA has reviewed the peer
reviewers' comments and determined which comments will be included in the
profile. A listing of the peer reviewers' comments not incorporated in the
profile, with a brief explanation of the rationale for their exclusion, exists
as part of the administrative record for this compound. A list of databases
reviewed and a list of unpublished documents cited are also included in the
administrative record.
The citation of the peer review panel should not be understood to imply
its approval of the profile's final content. The responsibility for the content
of this profile lies with the Agency for Toxic Substances and Disease Registry.
